ENDOSOMAL VACUOLAR PATHWAY
|
10
|
1.74e-04
|
-0.685000
|
1.80e-03
|
ER PHAGOSOME PATHWAY
|
19
|
9.27e-05
|
-0.518000
|
1.11e-03
|
GENERATION OF SECOND MESSENGER MOLECULES
|
12
|
1.89e-03
|
-0.518000
|
1.25e-02
|
INITIAL TRIGGERING OF COMPLEMENT
|
13
|
1.50e-03
|
-0.509000
|
1.07e-02
|
NCAM1 INTERACTIONS
|
16
|
5.23e-04
|
-0.501000
|
4.40e-03
|
RAP1 SIGNALLING
|
15
|
9.01e-04
|
-0.495000
|
6.82e-03
|
RHO GTPASES ACTIVATE KTN1
|
10
|
6.99e-03
|
-0.493000
|
3.53e-02
|
ANTIGEN PROCESSING CROSS PRESENTATION
|
72
|
1.84e-12
|
-0.480000
|
3.31e-10
|
RETROGRADE NEUROTROPHIN SIGNALLING
|
10
|
9.13e-03
|
-0.476000
|
4.32e-02
|
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
|
19
|
5.47e-04
|
-0.458000
|
4.56e-03
|
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
|
45
|
2.36e-07
|
-0.445000
|
1.25e-05
|
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY
|
11
|
1.08e-02
|
-0.444000
|
4.98e-02
|
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX
|
11
|
1.12e-02
|
-0.442000
|
5.07e-02
|
RHO GTPASES ACTIVATE NADPH OXIDASES
|
18
|
1.22e-03
|
-0.440000
|
8.89e-03
|
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
|
10
|
1.69e-02
|
-0.436000
|
6.71e-02
|
RAF INDEPENDENT MAPK1 3 ACTIVATION
|
20
|
7.45e-04
|
-0.436000
|
5.87e-03
|
SUMOYLATION OF IMMUNE RESPONSE PROTEINS
|
11
|
2.05e-02
|
-0.403000
|
7.76e-02
|
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
|
52
|
5.42e-07
|
-0.402000
|
2.44e-05
|
GPVI MEDIATED ACTIVATION CASCADE
|
29
|
2.28e-04
|
-0.395000
|
2.23e-03
|
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA
|
12
|
1.79e-02
|
-0.395000
|
7.02e-02
|
ACYL CHAIN REMODELLING OF PG
|
10
|
3.23e-02
|
-0.391000
|
1.08e-01
|
DAP12 INTERACTIONS
|
31
|
2.08e-04
|
-0.385000
|
2.08e-03
|
POLYMERASE SWITCHING
|
14
|
1.30e-02
|
0.383000
|
5.63e-02
|
PECAM1 INTERACTIONS
|
11
|
2.81e-02
|
-0.382000
|
9.83e-02
|
COMPLEMENT CASCADE
|
26
|
7.50e-04
|
-0.382000
|
5.87e-03
|
ISG15 ANTIVIRAL MECHANISM
|
27
|
5.94e-04
|
-0.382000
|
4.86e-03
|
PURINE SALVAGE
|
11
|
2.98e-02
|
0.378000
|
1.02e-01
|
G PROTEIN ACTIVATION
|
15
|
1.14e-02
|
-0.378000
|
5.11e-02
|
SEMA3A PAK DEPENDENT AXON REPULSION
|
14
|
1.45e-02
|
-0.377000
|
6.10e-02
|
GLUTATHIONE SYNTHESIS AND RECYCLING
|
11
|
3.15e-02
|
-0.374000
|
1.07e-01
|
MITOCHONDRIAL CALCIUM ION TRANSPORT
|
14
|
1.59e-02
|
-0.372000
|
6.47e-02
|
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR
|
14
|
1.60e-02
|
-0.372000
|
6.47e-02
|
G BETA GAMMA SIGNALLING THROUGH CDC42
|
15
|
1.38e-02
|
-0.367000
|
5.90e-02
|
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
|
18
|
7.01e-03
|
-0.367000
|
3.53e-02
|
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
|
42
|
4.11e-05
|
-0.366000
|
6.61e-04
|
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
|
15
|
1.52e-02
|
-0.362000
|
6.32e-02
|
PLASMA LIPOPROTEIN ASSEMBLY
|
13
|
2.55e-02
|
-0.358000
|
9.07e-02
|
CELL EXTRACELLULAR MATRIX INTERACTIONS
|
18
|
8.66e-03
|
-0.357000
|
4.15e-02
|
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
|
26
|
1.75e-03
|
-0.355000
|
1.18e-02
|
METALLOPROTEASE DUBS
|
17
|
1.16e-02
|
0.354000
|
5.17e-02
|
ANTIMICROBIAL PEPTIDES
|
11
|
4.26e-02
|
-0.353000
|
1.37e-01
|
NUCLEAR SIGNALING BY ERBB4
|
11
|
4.29e-02
|
0.353000
|
1.37e-01
|
POST NMDA RECEPTOR ACTIVATION EVENTS
|
14
|
2.26e-02
|
-0.352000
|
8.25e-02
|
HS GAG BIOSYNTHESIS
|
21
|
5.51e-03
|
-0.350000
|
2.95e-02
|
GAP JUNCTION ASSEMBLY
|
18
|
1.11e-02
|
-0.346000
|
5.07e-02
|
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING
|
54
|
1.21e-05
|
-0.344000
|
2.80e-04
|
PLATELET SENSITIZATION BY LDL
|
16
|
1.73e-02
|
-0.344000
|
6.78e-02
|
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND
|
15
|
2.12e-02
|
0.344000
|
7.90e-02
|
NON INTEGRIN MEMBRANE ECM INTERACTIONS
|
30
|
1.16e-03
|
-0.343000
|
8.53e-03
|
CA DEPENDENT EVENTS
|
25
|
3.04e-03
|
-0.342000
|
1.87e-02
|
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1
|
19
|
9.87e-03
|
-0.342000
|
4.58e-02
|
DEGRADATION OF AXIN
|
52
|
2.01e-05
|
-0.342000
|
3.93e-04
|
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME
|
54
|
1.39e-05
|
-0.342000
|
2.98e-04
|
RHO GTPASES ACTIVATE PAKS
|
22
|
5.72e-03
|
-0.340000
|
2.99e-02
|
CROSSLINKING OF COLLAGEN FIBRILS
|
18
|
1.25e-02
|
-0.340000
|
5.46e-02
|
COLLAGEN CHAIN TRIMERIZATION
|
34
|
6.05e-04
|
-0.340000
|
4.90e-03
|
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
|
20
|
8.62e-03
|
-0.339000
|
4.15e-02
|
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
|
53
|
2.13e-05
|
-0.338000
|
3.99e-04
|
TNFR2 NON CANONICAL NF KB PATHWAY
|
75
|
4.51e-07
|
-0.337000
|
2.14e-05
|
CYTOSOLIC SULFONATION OF SMALL MOLECULES
|
12
|
4.35e-02
|
-0.337000
|
1.38e-01
|
PKA MEDIATED PHOSPHORYLATION OF CREB
|
16
|
2.00e-02
|
-0.336000
|
7.65e-02
|
SHC1 EVENTS IN EGFR SIGNALING
|
11
|
5.41e-02
|
-0.335000
|
1.59e-01
|
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
|
18
|
1.41e-02
|
-0.334000
|
5.95e-02
|
SIGNALING BY PDGF
|
50
|
4.36e-05
|
-0.334000
|
6.66e-04
|
ERBB2 REGULATES CELL MOTILITY
|
12
|
4.59e-02
|
-0.333000
|
1.43e-01
|
LDL CLEARANCE
|
15
|
2.59e-02
|
-0.332000
|
9.15e-02
|
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
|
49
|
6.46e-05
|
-0.330000
|
9.03e-04
|
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION
|
27
|
3.09e-03
|
-0.329000
|
1.88e-02
|
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
|
68
|
2.81e-06
|
-0.329000
|
9.37e-05
|
DETOXIFICATION OF REACTIVE OXYGEN SPECIES
|
30
|
1.84e-03
|
-0.329000
|
1.23e-02
|
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS
|
16
|
2.32e-02
|
-0.328000
|
8.38e-02
|
REGULATION OF ENDOGENOUS RETROELEMENTS
|
28
|
2.73e-03
|
0.327000
|
1.73e-02
|
RHOH GTPASE CYCLE
|
31
|
1.67e-03
|
-0.326000
|
1.13e-02
|
NUCLEAR EVENTS MEDIATED BY NFE2L2
|
53
|
4.19e-05
|
-0.325000
|
6.61e-04
|
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE
|
23
|
7.10e-03
|
0.324000
|
3.55e-02
|
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION
|
17
|
2.08e-02
|
-0.324000
|
7.83e-02
|
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY
|
50
|
7.87e-05
|
-0.323000
|
1.01e-03
|
HEDGEHOG LIGAND BIOGENESIS
|
56
|
3.06e-05
|
-0.322000
|
5.30e-04
|
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
|
10
|
7.82e-02
|
-0.322000
|
2.05e-01
|
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
|
13
|
4.60e-02
|
-0.320000
|
1.43e-01
|
METABOLISM OF POLYAMINES
|
54
|
4.98e-05
|
-0.319000
|
7.48e-04
|
CELLULAR RESPONSE TO HYPOXIA
|
65
|
8.99e-06
|
-0.319000
|
2.31e-04
|
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
|
11
|
7.19e-02
|
-0.313000
|
1.93e-01
|
DISSOLUTION OF FIBRIN CLOT
|
10
|
8.66e-02
|
-0.313000
|
2.21e-01
|
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS
|
81
|
1.21e-06
|
-0.312000
|
4.75e-05
|
SYNDECAN INTERACTIONS
|
14
|
4.42e-02
|
-0.311000
|
1.40e-01
|
ACTIVATION OF APC C AND APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
|
72
|
5.35e-06
|
-0.310000
|
1.50e-04
|
RHO GTPASES ACTIVATE IQGAPS
|
26
|
6.25e-03
|
-0.310000
|
3.20e-02
|
METABOLISM OF FAT SOLUBLE VITAMINS
|
31
|
2.91e-03
|
-0.309000
|
1.81e-02
|
DEGRADATION OF DVL
|
53
|
1.00e-04
|
-0.309000
|
1.17e-03
|
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
|
71
|
6.92e-06
|
-0.309000
|
1.85e-04
|
STABILIZATION OF P53
|
52
|
1.20e-04
|
-0.308000
|
1.32e-03
|
TRIGLYCERIDE METABOLISM
|
12
|
6.54e-02
|
-0.307000
|
1.83e-01
|
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
|
53
|
1.12e-04
|
-0.307000
|
1.26e-03
|
SYNTHESIS OF BILE ACIDS AND BILE SALTS
|
24
|
9.36e-03
|
-0.306000
|
4.41e-02
|
TCR SIGNALING
|
90
|
6.46e-07
|
-0.304000
|
2.70e-05
|
ECM PROTEOGLYCANS
|
35
|
1.96e-03
|
-0.303000
|
1.29e-02
|
TRANSCRIPTIONAL REGULATION BY RUNX2
|
60
|
5.38e-05
|
-0.302000
|
7.69e-04
|
RECYCLING PATHWAY OF L1
|
33
|
2.74e-03
|
-0.301000
|
1.73e-02
|
GAB1 SIGNALOSOME
|
15
|
4.37e-02
|
-0.301000
|
1.39e-01
|
ACYL CHAIN REMODELLING OF PS
|
14
|
5.15e-02
|
-0.301000
|
1.53e-01
|
ACTIVATION OF NF KAPPAB IN B CELLS
|
59
|
6.96e-05
|
-0.300000
|
9.49e-04
|
REGULATION OF RAS BY GAPS
|
63
|
4.05e-05
|
-0.299000
|
6.61e-04
|
ROS AND RNS PRODUCTION IN PHAGOCYTES
|
29
|
5.50e-03
|
-0.298000
|
2.95e-02
|
ACYL CHAIN REMODELLING OF PE
|
15
|
4.66e-02
|
-0.297000
|
1.44e-01
|
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
|
56
|
1.32e-04
|
-0.295000
|
1.44e-03
|
CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6
|
69
|
2.26e-05
|
-0.295000
|
4.16e-04
|
G PROTEIN BETA GAMMA SIGNALLING
|
27
|
8.05e-03
|
-0.295000
|
3.96e-02
|
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS
|
22
|
1.68e-02
|
-0.294000
|
6.70e-02
|
LAMININ INTERACTIONS
|
15
|
4.88e-02
|
-0.294000
|
1.48e-01
|
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS
|
12
|
7.82e-02
|
-0.294000
|
2.05e-01
|
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
|
23
|
1.50e-02
|
-0.293000
|
6.26e-02
|
PYROPTOSIS
|
16
|
4.35e-02
|
-0.292000
|
1.38e-01
|
UBIQUINOL BIOSYNTHESIS
|
11
|
9.42e-02
|
-0.292000
|
2.34e-01
|
INTRINSIC PATHWAY FOR APOPTOSIS
|
34
|
3.34e-03
|
-0.291000
|
1.99e-02
|
COLLAGEN FORMATION
|
65
|
5.16e-05
|
-0.290000
|
7.61e-04
|
DOWNSTREAM TCR SIGNALING
|
78
|
1.01e-05
|
-0.289000
|
2.52e-04
|
CD28 DEPENDENT VAV1 PATHWAY
|
11
|
9.70e-02
|
-0.289000
|
2.40e-01
|
MISMATCH REPAIR MMR DIRECTED BY MSH2 MSH3 MUTSBETA
|
10
|
1.16e-01
|
0.287000
|
2.78e-01
|
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
|
16
|
4.78e-02
|
-0.286000
|
1.47e-01
|
ABC FAMILY PROTEINS MEDIATED TRANSPORT
|
90
|
3.00e-06
|
-0.285000
|
9.65e-05
|
SIGNAL AMPLIFICATION
|
26
|
1.20e-02
|
-0.285000
|
5.34e-02
|
WNT5A DEPENDENT INTERNALIZATION OF FZD4
|
14
|
6.54e-02
|
-0.284000
|
1.83e-01
|
GPER1 SIGNALING
|
22
|
2.12e-02
|
-0.284000
|
7.90e-02
|
TRAF6 MEDIATED NF KB ACTIVATION
|
13
|
7.65e-02
|
-0.284000
|
2.02e-01
|
REGULATION OF FZD BY UBIQUITINATION
|
13
|
7.73e-02
|
0.283000
|
2.03e-01
|
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
|
14
|
6.77e-02
|
-0.282000
|
1.86e-01
|
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
|
81
|
1.18e-05
|
-0.282000
|
2.79e-04
|
ASYMMETRIC LOCALIZATION OF PCP PROTEINS
|
59
|
1.84e-04
|
-0.282000
|
1.88e-03
|
METAL ION SLC TRANSPORTERS
|
17
|
4.55e-02
|
-0.280000
|
1.43e-01
|
IRAK1 RECRUITS IKK COMPLEX
|
14
|
7.12e-02
|
0.279000
|
1.92e-01
|
PCP CE PATHWAY
|
82
|
1.34e-05
|
-0.278000
|
2.98e-04
|
LAGGING STRAND SYNTHESIS
|
20
|
3.20e-02
|
0.277000
|
1.07e-01
|
BILE ACID AND BILE SALT METABOLISM
|
28
|
1.12e-02
|
-0.277000
|
5.09e-02
|
COSTIMULATION BY THE CD28 FAMILY
|
52
|
5.62e-04
|
-0.277000
|
4.64e-03
|
AQUAPORIN MEDIATED TRANSPORT
|
25
|
1.71e-02
|
-0.276000
|
6.75e-02
|
HDR THROUGH MMEJ ALT NHEJ
|
12
|
9.97e-02
|
-0.274000
|
2.46e-01
|
G PROTEIN MEDIATED EVENTS
|
36
|
4.45e-03
|
-0.274000
|
2.52e-02
|
INTERLEUKIN 1 FAMILY SIGNALING
|
105
|
1.32e-06
|
-0.273000
|
4.95e-05
|
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY
|
11
|
1.17e-01
|
0.273000
|
2.78e-01
|
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
|
53
|
6.11e-04
|
-0.272000
|
4.91e-03
|
INTERLEUKIN 6 FAMILY SIGNALING
|
16
|
6.05e-02
|
-0.271000
|
1.71e-01
|
TERMINATION OF O GLYCAN BIOSYNTHESIS
|
10
|
1.39e-01
|
-0.271000
|
3.10e-01
|
APOPTOTIC FACTOR MEDIATED RESPONSE
|
14
|
7.99e-02
|
-0.270000
|
2.08e-01
|
COHESIN LOADING ONTO CHROMATIN
|
10
|
1.40e-01
|
0.270000
|
3.12e-01
|
MHC CLASS II ANTIGEN PRESENTATION
|
98
|
4.02e-06
|
-0.270000
|
1.20e-04
|
G ALPHA Z SIGNALLING EVENTS
|
27
|
1.56e-02
|
-0.269000
|
6.45e-02
|
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS
|
24
|
2.26e-02
|
-0.269000
|
8.25e-02
|
KEAP1 NFE2L2 PATHWAY
|
73
|
7.30e-05
|
-0.269000
|
9.81e-04
|
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS
|
61
|
2.99e-04
|
-0.268000
|
2.87e-03
|
FORMATION OF WDR5 CONTAINING HISTONE MODIFYING COMPLEXES
|
36
|
5.59e-03
|
0.267000
|
2.98e-02
|
FCERI MEDIATED NF KB ACTIVATION
|
70
|
1.16e-04
|
-0.267000
|
1.29e-03
|
CONDENSATION OF PROPHASE CHROMOSOMES
|
12
|
1.11e-01
|
-0.266000
|
2.66e-01
|
OTHER INTERLEUKIN SIGNALING
|
14
|
8.50e-02
|
-0.266000
|
2.19e-01
|
HS GAG DEGRADATION
|
19
|
4.58e-02
|
-0.265000
|
1.43e-01
|
COMPLEX III ASSEMBLY
|
17
|
5.92e-02
|
0.264000
|
1.70e-01
|
AGGREPHAGY
|
28
|
1.58e-02
|
-0.263000
|
6.47e-02
|
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
14
|
8.80e-02
|
-0.263000
|
2.24e-01
|
COLLAGEN DEGRADATION
|
39
|
4.51e-03
|
-0.263000
|
2.53e-02
|
SEMA4D IN SEMAPHORIN SIGNALING
|
15
|
8.07e-02
|
-0.261000
|
2.09e-01
|
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS
|
83
|
4.33e-05
|
-0.260000
|
6.66e-04
|
TELOMERE C STRAND SYNTHESIS INITIATION
|
11
|
1.38e-01
|
0.258000
|
3.10e-01
|
INTERLEUKIN RECEPTOR SHC SIGNALING
|
17
|
6.56e-02
|
-0.258000
|
1.83e-01
|
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM
|
40
|
4.95e-03
|
-0.257000
|
2.73e-02
|
ACTIVATION OF BH3 ONLY PROTEINS
|
17
|
6.75e-02
|
-0.256000
|
1.86e-01
|
CYTOPROTECTION BY HMOX1
|
44
|
3.30e-03
|
0.256000
|
1.98e-02
|
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
|
10
|
1.64e-01
|
0.254000
|
3.42e-01
|
SUMOYLATION OF INTRACELLULAR RECEPTORS
|
24
|
3.17e-02
|
0.253000
|
1.07e-01
|
TRP CHANNELS
|
15
|
8.97e-02
|
-0.253000
|
2.25e-01
|
INTERLEUKIN 1 SIGNALING
|
96
|
1.87e-05
|
-0.253000
|
3.73e-04
|
ORC1 REMOVAL FROM CHROMATIN
|
65
|
4.60e-04
|
-0.251000
|
4.03e-03
|
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS
|
14
|
1.04e-01
|
0.251000
|
2.54e-01
|
INTEGRIN CELL SURFACE INTERACTIONS
|
65
|
4.87e-04
|
-0.250000
|
4.14e-03
|
SUMOYLATION OF TRANSCRIPTION FACTORS
|
13
|
1.20e-01
|
0.249000
|
2.83e-01
|
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX
|
10
|
1.74e-01
|
0.248000
|
3.53e-01
|
RHO GTPASE EFFECTORS
|
217
|
4.04e-10
|
-0.247000
|
3.64e-08
|
PLATELET AGGREGATION PLUG FORMATION
|
30
|
1.99e-02
|
-0.246000
|
7.64e-02
|
MAPK6 MAPK4 SIGNALING
|
70
|
4.11e-04
|
-0.244000
|
3.73e-03
|
TELOMERE C STRAND LAGGING STRAND SYNTHESIS
|
31
|
1.89e-02
|
0.244000
|
7.34e-02
|
CD209 DC SIGN SIGNALING
|
16
|
9.20e-02
|
-0.243000
|
2.30e-01
|
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE
|
12
|
1.46e-01
|
0.243000
|
3.22e-01
|
CS DS DEGRADATION
|
11
|
1.64e-01
|
-0.243000
|
3.42e-01
|
ARACHIDONIC ACID METABOLISM
|
33
|
1.59e-02
|
-0.243000
|
6.47e-02
|
SIGNALING BY INTERLEUKINS
|
222
|
5.14e-10
|
-0.242000
|
4.21e-08
|
CLEC7A DECTIN 1 SIGNALING
|
88
|
8.57e-05
|
-0.242000
|
1.05e-03
|
INTEGRIN SIGNALING
|
26
|
3.28e-02
|
-0.242000
|
1.08e-01
|
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
|
86
|
1.07e-04
|
-0.242000
|
1.22e-03
|
HEPARAN SULFATE HEPARIN HS GAG METABOLISM
|
41
|
7.54e-03
|
-0.241000
|
3.73e-02
|
DOWNSTREAM SIGNAL TRANSDUCTION
|
26
|
3.38e-02
|
-0.240000
|
1.11e-01
|
CD28 DEPENDENT PI3K AKT SIGNALING
|
21
|
5.67e-02
|
-0.240000
|
1.64e-01
|
C TYPE LECTIN RECEPTORS CLRS
|
104
|
2.35e-05
|
-0.240000
|
4.23e-04
|
HEDGEHOG ON STATE
|
75
|
3.27e-04
|
-0.240000
|
3.07e-03
|
ERK MAPK TARGETS
|
19
|
7.14e-02
|
-0.239000
|
1.92e-01
|
GAP JUNCTION TRAFFICKING AND REGULATION
|
30
|
2.36e-02
|
-0.239000
|
8.50e-02
|
MAP2K AND MAPK ACTIVATION
|
36
|
1.32e-02
|
-0.239000
|
5.67e-02
|
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
|
17
|
8.86e-02
|
0.239000
|
2.24e-01
|
COPI MEDIATED ANTEROGRADE TRANSPORT
|
89
|
1.05e-04
|
-0.238000
|
1.22e-03
|
FCGR ACTIVATION
|
11
|
1.72e-01
|
-0.238000
|
3.52e-01
|
REGULATION OF PTEN STABILITY AND ACTIVITY
|
66
|
8.91e-04
|
-0.237000
|
6.80e-03
|
CHEMOKINE RECEPTORS BIND CHEMOKINES
|
20
|
6.72e-02
|
-0.236000
|
1.86e-01
|
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR
|
73
|
4.87e-04
|
-0.236000
|
4.14e-03
|
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
42
|
8.43e-03
|
-0.235000
|
4.12e-02
|
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY
|
68
|
8.38e-04
|
-0.234000
|
6.45e-03
|
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
|
10
|
2.00e-01
|
-0.234000
|
3.88e-01
|
HEDGEHOG OFF STATE
|
100
|
5.30e-05
|
-0.234000
|
7.69e-04
|
SIGNALING BY NTRK1 TRKA
|
62
|
1.49e-03
|
-0.233000
|
1.07e-02
|
PLATELET HOMEOSTASIS
|
64
|
1.26e-03
|
-0.233000
|
9.18e-03
|
BETA CATENIN INDEPENDENT WNT SIGNALING
|
112
|
2.08e-05
|
-0.233000
|
3.99e-04
|
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING
|
10
|
2.03e-01
|
-0.233000
|
3.90e-01
|
RHO GTPASES ACTIVATE PKNS
|
21
|
6.53e-02
|
-0.232000
|
1.83e-01
|
RHO GTPASES ACTIVATE WASPS AND WAVES
|
33
|
2.12e-02
|
-0.232000
|
7.90e-02
|
NICOTINAMIDE SALVAGING
|
15
|
1.23e-01
|
-0.230000
|
2.86e-01
|
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION
|
24
|
5.09e-02
|
-0.230000
|
1.52e-01
|
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS
|
13
|
1.51e-01
|
-0.230000
|
3.28e-01
|
INTRA GOLGI TRAFFIC
|
33
|
2.23e-02
|
-0.230000
|
8.23e-02
|
SYNTHESIS OF PE
|
10
|
2.08e-01
|
-0.230000
|
3.98e-01
|
PLATELET ACTIVATION SIGNALING AND AGGREGATION
|
214
|
7.47e-09
|
-0.230000
|
5.60e-07
|
SEMAPHORIN INTERACTIONS
|
50
|
5.14e-03
|
-0.229000
|
2.82e-02
|
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS
|
74
|
6.80e-04
|
-0.229000
|
5.41e-03
|
ACTIVATION OF SMO
|
10
|
2.11e-01
|
0.228000
|
4.02e-01
|
GLUCONEOGENESIS
|
19
|
8.51e-02
|
-0.228000
|
2.19e-01
|
INTERLEUKIN 20 FAMILY SIGNALING
|
11
|
1.90e-01
|
-0.228000
|
3.75e-01
|
KINESINS
|
47
|
6.85e-03
|
-0.228000
|
3.48e-02
|
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS
|
12
|
1.72e-01
|
-0.228000
|
3.52e-01
|
TRANSCRIPTIONAL REGULATION BY E2F6
|
23
|
6.01e-02
|
0.227000
|
1.71e-01
|
COMPLEX IV ASSEMBLY
|
38
|
1.59e-02
|
0.226000
|
6.47e-02
|
SIGNALING BY THE B CELL RECEPTOR BCR
|
94
|
1.57e-04
|
-0.226000
|
1.68e-03
|
GLUCAGON TYPE LIGAND RECEPTORS
|
17
|
1.10e-01
|
-0.224000
|
2.65e-01
|
BIOTIN TRANSPORT AND METABOLISM
|
11
|
2.01e-01
|
-0.223000
|
3.89e-01
|
OPIOID SIGNALLING
|
59
|
3.10e-03
|
-0.223000
|
1.88e-02
|
INTERACTION BETWEEN L1 AND ANKYRINS
|
10
|
2.23e-01
|
-0.222000
|
4.15e-01
|
OTHER SEMAPHORIN INTERACTIONS
|
14
|
1.51e-01
|
-0.222000
|
3.28e-01
|
REGULATION OF BACH1 ACTIVITY
|
10
|
2.25e-01
|
0.221000
|
4.16e-01
|
RHOBTB1 GTPASE CYCLE
|
22
|
7.24e-02
|
0.221000
|
1.94e-01
|
G1 S DNA DAMAGE CHECKPOINTS
|
61
|
2.91e-03
|
-0.221000
|
1.81e-02
|
INTERLEUKIN 2 FAMILY SIGNALING
|
26
|
5.25e-02
|
-0.220000
|
1.55e-01
|
SIGNALING BY SCF KIT
|
33
|
2.92e-02
|
-0.219000
|
1.02e-01
|
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
|
15
|
1.41e-01
|
-0.219000
|
3.14e-01
|
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
86
|
4.67e-04
|
-0.218000
|
4.04e-03
|
NEUTROPHIL DEGRANULATION
|
386
|
2.30e-13
|
-0.218000
|
5.16e-11
|
ERKS ARE INACTIVATED
|
13
|
1.74e-01
|
-0.218000
|
3.53e-01
|
RHOV GTPASE CYCLE
|
34
|
2.80e-02
|
-0.218000
|
9.83e-02
|
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2
|
110
|
8.09e-05
|
-0.218000
|
1.01e-03
|
EXTRACELLULAR MATRIX ORGANIZATION
|
191
|
2.23e-07
|
-0.218000
|
1.25e-05
|
O LINKED GLYCOSYLATION OF MUCINS
|
30
|
3.92e-02
|
-0.218000
|
1.27e-01
|
UB SPECIFIC PROCESSING PROTEASES
|
151
|
4.14e-06
|
-0.217000
|
1.20e-04
|
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS
|
21
|
8.61e-02
|
-0.216000
|
2.20e-01
|
INNATE IMMUNE SYSTEM
|
712
|
1.65e-22
|
-0.216000
|
7.42e-20
|
SIGNALING BY VEGF
|
98
|
2.25e-04
|
-0.216000
|
2.23e-03
|
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING
|
36
|
2.58e-02
|
-0.215000
|
9.15e-02
|
ADENYLATE CYCLASE INHIBITORY PATHWAY
|
13
|
1.80e-01
|
-0.215000
|
3.63e-01
|
EXTRA NUCLEAR ESTROGEN SIGNALING
|
60
|
4.16e-03
|
-0.214000
|
2.42e-02
|
PTEN REGULATION
|
95
|
3.24e-04
|
-0.214000
|
3.07e-03
|
DEGRADATION OF THE EXTRACELLULAR MATRIX
|
79
|
1.05e-03
|
-0.213000
|
7.80e-03
|
SIGNALING BY HEDGEHOG
|
125
|
3.85e-05
|
-0.213000
|
6.42e-04
|
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER
|
26
|
5.99e-02
|
0.213000
|
1.71e-01
|
NCAM SIGNALING FOR NEURITE OUT GROWTH
|
34
|
3.16e-02
|
-0.213000
|
1.07e-01
|
REGULATION OF NF KAPPA B SIGNALING
|
16
|
1.40e-01
|
-0.213000
|
3.12e-01
|
FORMATION OF THE CORNIFIED ENVELOPE
|
17
|
1.29e-01
|
-0.213000
|
2.95e-01
|
KERATINIZATION
|
17
|
1.29e-01
|
-0.213000
|
2.95e-01
|
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
|
20
|
1.00e-01
|
-0.212000
|
2.46e-01
|
GOLGI TO ER RETROGRADE TRANSPORT
|
116
|
8.65e-05
|
-0.211000
|
1.05e-03
|
RMTS METHYLATE HISTONE ARGININES
|
25
|
6.78e-02
|
-0.211000
|
1.86e-01
|
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
|
75
|
1.59e-03
|
-0.211000
|
1.09e-02
|
UCH PROTEINASES
|
77
|
1.58e-03
|
-0.208000
|
1.09e-02
|
DNA REPLICATION PRE INITIATION
|
97
|
4.00e-04
|
-0.208000
|
3.68e-03
|
SMOOTH MUSCLE CONTRACTION
|
29
|
5.24e-02
|
-0.208000
|
1.55e-01
|
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC
|
169
|
3.18e-06
|
-0.208000
|
9.88e-05
|
EPHB MEDIATED FORWARD SIGNALING
|
35
|
3.35e-02
|
-0.208000
|
1.10e-01
|
FANCONI ANEMIA PATHWAY
|
33
|
4.00e-02
|
0.207000
|
1.29e-01
|
ADAPTIVE IMMUNE SYSTEM
|
566
|
7.14e-17
|
-0.206000
|
2.14e-14
|
RESPIRATORY ELECTRON TRANSPORT
|
124
|
7.71e-05
|
0.206000
|
1.01e-03
|
CHONDROITIN SULFATE BIOSYNTHESIS
|
16
|
1.55e-01
|
-0.205000
|
3.35e-01
|
REGULATION OF KIT SIGNALING
|
12
|
2.18e-01
|
-0.205000
|
4.11e-01
|
PLASMA LIPOPROTEIN CLEARANCE
|
28
|
6.04e-02
|
-0.205000
|
1.71e-01
|
SIGNALING BY CSF3 G CSF
|
19
|
1.23e-01
|
-0.205000
|
2.86e-01
|
IMMUNE SYSTEM
|
1247
|
3.05e-33
|
-0.204000
|
2.75e-30
|
ER TO GOLGI ANTEROGRADE TRANSPORT
|
139
|
3.44e-05
|
-0.204000
|
5.84e-04
|
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
|
164
|
6.99e-06
|
-0.204000
|
1.85e-04
|
ADENYLATE CYCLASE ACTIVATING PATHWAY
|
10
|
2.65e-01
|
-0.203000
|
4.62e-01
|
DAP12 SIGNALING
|
21
|
1.07e-01
|
-0.203000
|
2.59e-01
|
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS
|
81
|
1.59e-03
|
-0.203000
|
1.09e-02
|
TRANSCRIPTIONAL REGULATION BY RUNX3
|
76
|
2.33e-03
|
-0.202000
|
1.51e-02
|
RECEPTOR MEDIATED MITOPHAGY
|
11
|
2.48e-01
|
0.201000
|
4.42e-01
|
RUNX3 REGULATES NOTCH SIGNALING
|
10
|
2.71e-01
|
0.201000
|
4.67e-01
|
CD28 CO STIMULATION
|
31
|
5.38e-02
|
-0.200000
|
1.59e-01
|
LYSOSOME VESICLE BIOGENESIS
|
30
|
5.83e-02
|
-0.200000
|
1.68e-01
|
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK IKBKE
|
17
|
1.55e-01
|
-0.199000
|
3.35e-01
|
VISUAL PHOTOTRANSDUCTION
|
51
|
1.41e-02
|
-0.199000
|
5.95e-02
|
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION
|
17
|
1.57e-01
|
0.198000
|
3.36e-01
|
SIGNALING BY NTRKS
|
73
|
3.69e-03
|
-0.197000
|
2.19e-02
|
RNA POLYMERASE III TRANSCRIPTION
|
34
|
4.82e-02
|
0.196000
|
1.48e-01
|
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE
|
11
|
2.64e-01
|
-0.195000
|
4.61e-01
|
NUCLEOTIDE SALVAGE
|
19
|
1.43e-01
|
0.194000
|
3.17e-01
|
INACTIVATION OF CSF3 G CSF SIGNALING
|
15
|
1.93e-01
|
-0.194000
|
3.80e-01
|
INTRACELLULAR SIGNALING BY SECOND MESSENGERS
|
224
|
6.60e-07
|
-0.193000
|
2.70e-05
|
MAPK FAMILY SIGNALING CASCADES
|
258
|
1.01e-07
|
-0.193000
|
6.52e-06
|
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
|
58
|
1.11e-02
|
-0.193000
|
5.07e-02
|
TRANSLESION SYNTHESIS BY POLK
|
17
|
1.69e-01
|
0.193000
|
3.50e-01
|
MISCELLANEOUS TRANSPORT AND BINDING EVENTS
|
18
|
1.57e-01
|
-0.193000
|
3.36e-01
|
CYTOKINE SIGNALING IN IMMUNE SYSTEM
|
360
|
3.98e-10
|
-0.193000
|
3.64e-08
|
EPIGENETIC REGULATION OF GENE EXPRESSION
|
103
|
7.60e-04
|
0.192000
|
5.90e-03
|
HEMOSTASIS
|
424
|
1.46e-11
|
-0.192000
|
2.19e-09
|
MET ACTIVATES PTK2 SIGNALING
|
18
|
1.59e-01
|
-0.192000
|
3.36e-01
|
SYNAPTIC ADHESION LIKE MOLECULES
|
15
|
1.99e-01
|
-0.192000
|
3.88e-01
|
EXTENSION OF TELOMERES
|
43
|
2.99e-02
|
0.191000
|
1.02e-01
|
G ALPHA I SIGNALLING EVENTS
|
129
|
1.94e-04
|
-0.190000
|
1.96e-03
|
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
14
|
2.18e-01
|
-0.190000
|
4.11e-01
|
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS
|
11
|
2.76e-01
|
-0.190000
|
4.72e-01
|
L1CAM INTERACTIONS
|
63
|
9.45e-03
|
-0.189000
|
4.43e-02
|
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
|
10
|
3.01e-01
|
-0.189000
|
5.01e-01
|
COMPLEX I BIOGENESIS
|
58
|
1.30e-02
|
0.189000
|
5.63e-02
|
CRMPS IN SEMA3A SIGNALING
|
14
|
2.22e-01
|
-0.189000
|
4.15e-01
|
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL
|
23
|
1.19e-01
|
-0.188000
|
2.81e-01
|
GOLGI ASSOCIATED VESICLE BIOGENESIS
|
51
|
2.03e-02
|
-0.188000
|
7.71e-02
|
GLYCOSPHINGOLIPID BIOSYNTHESIS
|
14
|
2.25e-01
|
-0.187000
|
4.16e-01
|
SIGNALING BY BMP
|
23
|
1.21e-01
|
-0.187000
|
2.84e-01
|
CLATHRIN MEDIATED ENDOCYTOSIS
|
120
|
4.42e-04
|
-0.186000
|
3.96e-03
|
VEGFR2 MEDIATED CELL PROLIFERATION
|
12
|
2.66e-01
|
-0.185000
|
4.62e-01
|
NUCLEAR ENVELOPE NE REASSEMBLY
|
61
|
1.25e-02
|
-0.185000
|
5.46e-02
|
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION
|
16
|
2.03e-01
|
-0.184000
|
3.90e-01
|
METABOLISM OF FOLATE AND PTERINES
|
17
|
1.89e-01
|
0.184000
|
3.74e-01
|
TRANS GOLGI NETWORK VESICLE BUDDING
|
66
|
9.82e-03
|
-0.184000
|
4.58e-02
|
BBSOME MEDIATED CARGO TARGETING TO CILIUM
|
11
|
2.91e-01
|
0.184000
|
4.90e-01
|
TELOMERE MAINTENANCE
|
47
|
2.99e-02
|
0.183000
|
1.02e-01
|
SIGNALING BY ACTIVIN
|
14
|
2.36e-01
|
-0.183000
|
4.28e-01
|
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS
|
20
|
1.57e-01
|
-0.183000
|
3.36e-01
|
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE
|
18
|
1.80e-01
|
0.182000
|
3.63e-01
|
PHOSPHORYLATION OF THE APC C
|
19
|
1.69e-01
|
-0.182000
|
3.50e-01
|
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
|
14
|
2.40e-01
|
0.181000
|
4.32e-01
|
SEPARATION OF SISTER CHROMATIDS
|
165
|
6.52e-05
|
-0.180000
|
9.03e-04
|
MITOTIC METAPHASE AND ANAPHASE
|
202
|
1.09e-05
|
-0.180000
|
2.65e-04
|
EPHRIN SIGNALING
|
18
|
1.89e-01
|
-0.179000
|
3.74e-01
|
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS
|
14
|
2.48e-01
|
0.178000
|
4.42e-01
|
GABA B RECEPTOR ACTIVATION
|
33
|
7.65e-02
|
-0.178000
|
2.02e-01
|
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
|
86
|
4.44e-03
|
-0.178000
|
2.52e-02
|
NEGATIVE REGULATION OF MAPK PATHWAY
|
41
|
4.95e-02
|
-0.177000
|
1.50e-01
|
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
|
19
|
1.81e-01
|
-0.177000
|
3.63e-01
|
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY
|
17
|
2.08e-01
|
-0.176000
|
3.98e-01
|
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE
|
51
|
2.95e-02
|
-0.176000
|
1.02e-01
|
AEROBIC RESPIRATION AND RESPIRATORY ELECTRON TRANSPORT
|
202
|
1.65e-05
|
0.176000
|
3.38e-04
|
SIGNALING BY RECEPTOR TYROSINE KINASES
|
359
|
1.12e-08
|
-0.176000
|
7.76e-07
|
INTERFERON ALPHA BETA SIGNALING
|
19
|
1.85e-01
|
-0.176000
|
3.68e-01
|
REPRODUCTION
|
11
|
3.13e-01
|
0.176000
|
5.12e-01
|
TNFR1 INDUCED PROAPOPTOTIC SIGNALING
|
22
|
1.55e-01
|
-0.175000
|
3.35e-01
|
FC EPSILON RECEPTOR FCERI SIGNALING
|
110
|
1.55e-03
|
-0.175000
|
1.09e-02
|
SENSORY PERCEPTION
|
56
|
2.39e-02
|
-0.175000
|
8.54e-02
|
MET PROMOTES CELL MOTILITY
|
28
|
1.12e-01
|
-0.173000
|
2.69e-01
|
N GLYCAN ANTENNAE ELONGATION
|
13
|
2.80e-01
|
-0.173000
|
4.78e-01
|
INWARDLY RECTIFYING K CHANNELS
|
25
|
1.37e-01
|
-0.172000
|
3.10e-01
|
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
|
25
|
1.38e-01
|
-0.171000
|
3.10e-01
|
RAC1 GTPASE CYCLE
|
162
|
1.74e-04
|
-0.171000
|
1.80e-03
|
RHOU GTPASE CYCLE
|
38
|
6.80e-02
|
-0.171000
|
1.86e-01
|
APOPTOSIS
|
89
|
5.45e-03
|
-0.171000
|
2.95e-02
|
RAC2 GTPASE CYCLE
|
80
|
8.54e-03
|
-0.170000
|
4.15e-02
|
DNA STRAND ELONGATION
|
24
|
1.49e-01
|
0.170000
|
3.26e-01
|
RHOF GTPASE CYCLE
|
39
|
6.79e-02
|
-0.169000
|
1.86e-01
|
GLYCOSAMINOGLYCAN METABOLISM
|
98
|
3.89e-03
|
-0.169000
|
2.27e-02
|
PROGRAMMED CELL DEATH
|
117
|
1.65e-03
|
-0.169000
|
1.13e-02
|
TOLL LIKE RECEPTOR 4 TLR4 CASCADE
|
112
|
2.08e-03
|
-0.169000
|
1.36e-02
|
PEPTIDE LIGAND BINDING RECEPTORS
|
57
|
2.98e-02
|
-0.166000
|
1.02e-01
|
GLYCOGEN METABOLISM
|
17
|
2.35e-01
|
-0.166000
|
4.28e-01
|
REDUCTION OF CYTOSOLIC CA LEVELS
|
12
|
3.20e-01
|
-0.166000
|
5.18e-01
|
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
|
10
|
3.65e-01
|
0.166000
|
5.71e-01
|
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER
|
27
|
1.37e-01
|
0.165000
|
3.10e-01
|
SHC1 EVENTS IN ERBB4 SIGNALING
|
10
|
3.67e-01
|
-0.165000
|
5.71e-01
|
BRANCHED CHAIN AMINO ACID CATABOLISM
|
20
|
2.04e-01
|
0.164000
|
3.92e-01
|
TAK1 DEPENDENT IKK AND NF KAPPA B ACTIVATION
|
36
|
8.87e-02
|
-0.164000
|
2.24e-01
|
PRC2 METHYLATES HISTONES AND DNA
|
15
|
2.72e-01
|
0.164000
|
4.68e-01
|
VESICLE MEDIATED TRANSPORT
|
522
|
2.40e-10
|
-0.163000
|
2.70e-08
|
INTERLEUKIN 7 SIGNALING
|
12
|
3.32e-01
|
-0.162000
|
5.34e-01
|
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS
|
28
|
1.39e-01
|
-0.162000
|
3.10e-01
|
ASPARAGINE N LINKED GLYCOSYLATION
|
241
|
1.61e-05
|
-0.162000
|
3.38e-04
|
METHYLATION
|
13
|
3.14e-01
|
-0.161000
|
5.12e-01
|
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION
|
99
|
5.66e-03
|
-0.161000
|
2.99e-02
|
COPII MEDIATED VESICLE TRANSPORT
|
66
|
2.38e-02
|
-0.161000
|
8.54e-02
|
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE
|
14
|
2.99e-01
|
-0.160000
|
5.01e-01
|
REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
|
32
|
1.17e-01
|
-0.160000
|
2.78e-01
|
NEGATIVE REGULATION OF THE PI3K AKT NETWORK
|
90
|
8.91e-03
|
-0.160000
|
4.24e-02
|
ACYL CHAIN REMODELLING OF PC
|
17
|
2.56e-01
|
-0.159000
|
4.51e-01
|
CARGO CONCENTRATION IN THE ER
|
29
|
1.38e-01
|
-0.159000
|
3.10e-01
|
REGULATION OF PTEN GENE TRANSCRIPTION
|
27
|
1.53e-01
|
-0.159000
|
3.33e-01
|
MITOTIC G2 G2 M PHASES
|
171
|
3.51e-04
|
-0.159000
|
3.26e-03
|
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS
|
51
|
5.05e-02
|
0.158000
|
1.52e-01
|
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES
|
28
|
1.48e-01
|
-0.158000
|
3.25e-01
|
CELL CELL COMMUNICATION
|
70
|
2.25e-02
|
-0.158000
|
8.25e-02
|
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3
|
564
|
1.98e-10
|
-0.158000
|
2.54e-08
|
RAB GEFS EXCHANGE GTP FOR GDP ON RABS
|
84
|
1.31e-02
|
-0.157000
|
5.63e-02
|
TOLL LIKE RECEPTOR CASCADES
|
138
|
1.51e-03
|
-0.157000
|
1.07e-02
|
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION
|
314
|
2.10e-06
|
-0.156000
|
7.28e-05
|
RHO GTPASES ACTIVATE FORMINS
|
116
|
3.81e-03
|
-0.156000
|
2.24e-02
|
CITRIC ACID CYCLE TCA CYCLE
|
33
|
1.23e-01
|
0.155000
|
2.86e-01
|
DEPOLYMERIZATION OF THE NUCLEAR LAMINA
|
11
|
3.73e-01
|
-0.155000
|
5.77e-01
|
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK
|
44
|
7.58e-02
|
-0.155000
|
2.01e-01
|
SIGNALING BY HIPPO
|
20
|
2.31e-01
|
-0.155000
|
4.25e-01
|
CLASS A 1 RHODOPSIN LIKE RECEPTORS
|
107
|
5.79e-03
|
-0.155000
|
2.99e-02
|
SUMOYLATION OF TRANSCRIPTION COFACTORS
|
37
|
1.04e-01
|
0.154000
|
2.54e-01
|
ACTIVATION OF G PROTEIN GATED POTASSIUM CHANNELS
|
20
|
2.33e-01
|
-0.154000
|
4.27e-01
|
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES
|
14
|
3.18e-01
|
0.154000
|
5.17e-01
|
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS
|
82
|
1.61e-02
|
-0.154000
|
6.48e-02
|
REGULATION OF PYRUVATE METABOLISM
|
32
|
1.32e-01
|
0.154000
|
3.02e-01
|
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER
|
22
|
2.16e-01
|
0.152000
|
4.09e-01
|
EUKARYOTIC TRANSLATION INITIATION
|
112
|
5.48e-03
|
-0.152000
|
2.95e-02
|
REGULATION OF TBK1 IKK IKBKE MEDIATED ACTIVATION OF IRF3 IRF7
|
14
|
3.25e-01
|
-0.152000
|
5.25e-01
|
CTLA4 INHIBITORY SIGNALING
|
20
|
2.40e-01
|
-0.152000
|
4.32e-01
|
IRS MEDIATED SIGNALLING
|
28
|
1.65e-01
|
-0.152000
|
3.44e-01
|
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE
|
11
|
3.84e-01
|
0.152000
|
5.88e-01
|
SHC MEDIATED CASCADE FGFR1
|
11
|
3.85e-01
|
-0.151000
|
5.88e-01
|
SHC1 EVENTS IN ERBB2 SIGNALING
|
13
|
3.46e-01
|
-0.151000
|
5.50e-01
|
BETA CATENIN PHOSPHORYLATION CASCADE
|
17
|
2.82e-01
|
-0.151000
|
4.80e-01
|
INSULIN RECEPTOR RECYCLING
|
24
|
2.02e-01
|
-0.151000
|
3.90e-01
|
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX
|
29
|
1.62e-01
|
0.150000
|
3.41e-01
|
NERVOUS SYSTEM DEVELOPMENT
|
235
|
8.02e-05
|
-0.150000
|
1.01e-03
|
DEADENYLATION OF MRNA
|
22
|
2.25e-01
|
-0.149000
|
4.16e-01
|
ACTIVATION OF MATRIX METALLOPROTEINASES
|
19
|
2.61e-01
|
-0.149000
|
4.58e-01
|
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS
|
23
|
2.18e-01
|
-0.148000
|
4.11e-01
|
RA BIOSYNTHESIS PATHWAY
|
15
|
3.20e-01
|
-0.148000
|
5.18e-01
|
ELASTIC FIBRE FORMATION
|
36
|
1.24e-01
|
-0.148000
|
2.86e-01
|
METABOLISM OF CARBOHYDRATES
|
219
|
1.60e-04
|
-0.148000
|
1.69e-03
|
PHASE II CONJUGATION OF COMPOUNDS
|
69
|
3.34e-02
|
-0.148000
|
1.10e-01
|
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA
|
16
|
3.06e-01
|
0.148000
|
5.06e-01
|
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN
|
32
|
1.49e-01
|
0.148000
|
3.25e-01
|
PI 3K CASCADE FGFR1
|
12
|
3.78e-01
|
-0.147000
|
5.82e-01
|
OVARIAN TUMOR DOMAIN PROTEASES
|
31
|
1.59e-01
|
-0.146000
|
3.36e-01
|
MITOTIC G1 PHASE AND G1 S TRANSITION
|
126
|
4.82e-03
|
-0.146000
|
2.68e-02
|
G2 M CHECKPOINTS
|
121
|
5.74e-03
|
-0.146000
|
2.99e-02
|
DNA REPLICATION
|
121
|
5.84e-03
|
-0.145000
|
3.00e-02
|
CHOLESTEROL BIOSYNTHESIS
|
26
|
2.00e-01
|
0.145000
|
3.88e-01
|
EPH EPHRIN SIGNALING
|
57
|
6.05e-02
|
-0.144000
|
1.71e-01
|
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA
|
30
|
1.73e-01
|
-0.144000
|
3.53e-01
|
M PHASE
|
312
|
1.37e-05
|
-0.144000
|
2.98e-04
|
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE
|
49
|
8.25e-02
|
-0.143000
|
2.13e-01
|
HYALURONAN UPTAKE AND DEGRADATION
|
11
|
4.11e-01
|
-0.143000
|
6.10e-01
|
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN
|
10
|
4.33e-01
|
0.143000
|
6.38e-01
|
MOLECULES ASSOCIATED WITH ELASTIC FIBRES
|
29
|
1.84e-01
|
-0.143000
|
3.68e-01
|
REGULATION OF CDH11 EXPRESSION AND FUNCTION
|
11
|
4.13e-01
|
0.143000
|
6.13e-01
|
SELECTIVE AUTOPHAGY
|
63
|
5.08e-02
|
-0.142000
|
1.52e-01
|
NICOTINATE METABOLISM
|
25
|
2.21e-01
|
-0.141000
|
4.15e-01
|
MITOCHONDRIAL BIOGENESIS
|
10
|
4.39e-01
|
0.141000
|
6.44e-01
|
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS
|
10
|
4.39e-01
|
0.141000
|
6.44e-01
|
SHC MEDIATED CASCADE FGFR2
|
12
|
3.99e-01
|
-0.141000
|
5.97e-01
|
GPCR LIGAND BINDING
|
139
|
4.32e-03
|
-0.140000
|
2.49e-02
|
REGULATED NECROSIS
|
45
|
1.06e-01
|
-0.139000
|
2.57e-01
|
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
|
15
|
3.50e-01
|
-0.139000
|
5.54e-01
|
GLUCOSE METABOLISM
|
64
|
5.46e-02
|
-0.139000
|
1.60e-01
|
PI3K EVENTS IN ERBB2 SIGNALING
|
13
|
3.86e-01
|
-0.139000
|
5.89e-01
|
G1 S TRANSITION
|
101
|
1.61e-02
|
-0.139000
|
6.48e-02
|
DEUBIQUITINATION
|
216
|
4.62e-04
|
-0.139000
|
4.03e-03
|
CELLULAR HEXOSE TRANSPORT
|
13
|
3.88e-01
|
-0.138000
|
5.89e-01
|
TRANSPORT OF SMALL MOLECULES
|
500
|
1.39e-07
|
-0.138000
|
8.36e-06
|
APC CDC20 MEDIATED DEGRADATION OF NEK2A
|
26
|
2.23e-01
|
-0.138000
|
4.15e-01
|
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1
|
22
|
2.64e-01
|
-0.138000
|
4.61e-01
|
SIALIC ACID METABOLISM
|
25
|
2.34e-01
|
-0.137000
|
4.28e-01
|
PI 3K CASCADE FGFR2
|
13
|
3.91e-01
|
-0.137000
|
5.90e-01
|
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX
|
11
|
4.31e-01
|
-0.137000
|
6.37e-01
|
CHAPERONIN MEDIATED PROTEIN FOLDING
|
31
|
1.87e-01
|
-0.137000
|
3.72e-01
|
RHOJ GTPASE CYCLE
|
15
|
3.60e-01
|
0.137000
|
5.66e-01
|
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM
|
13
|
3.94e-01
|
-0.137000
|
5.94e-01
|
GRB2 EVENTS IN ERBB2 SIGNALING
|
10
|
4.56e-01
|
-0.136000
|
6.58e-01
|
PENTOSE PHOSPHATE PATHWAY
|
14
|
3.79e-01
|
-0.136000
|
5.83e-01
|
REGULATION OF SIGNALING BY CBL
|
21
|
2.82e-01
|
-0.136000
|
4.80e-01
|
MISMATCH REPAIR
|
14
|
3.81e-01
|
0.135000
|
5.84e-01
|
REGULATED PROTEOLYSIS OF P75NTR
|
10
|
4.59e-01
|
0.135000
|
6.60e-01
|
METABOLISM OF STEROID HORMONES
|
15
|
3.66e-01
|
0.135000
|
5.71e-01
|
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY
|
24
|
2.53e-01
|
0.135000
|
4.49e-01
|
TRANSFERRIN ENDOCYTOSIS AND RECYCLING
|
25
|
2.44e-01
|
-0.135000
|
4.37e-01
|
SIGNALING BY MET
|
61
|
6.93e-02
|
-0.135000
|
1.88e-01
|
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
|
15
|
3.70e-01
|
0.134000
|
5.74e-01
|
VEGFR2 MEDIATED VASCULAR PERMEABILITY
|
29
|
2.13e-01
|
-0.134000
|
4.04e-01
|
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
|
86
|
3.27e-02
|
-0.133000
|
1.08e-01
|
CELLULAR RESPONSE TO CHEMICAL STRESS
|
145
|
5.73e-03
|
-0.133000
|
2.99e-02
|
PROLONGED ERK ACTIVATION EVENTS
|
13
|
4.09e-01
|
-0.132000
|
6.09e-01
|
PKMTS METHYLATE HISTONE LYSINES
|
36
|
1.70e-01
|
0.132000
|
3.50e-01
|
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR IN THE PRESENCE OF LIGAND
|
46
|
1.24e-01
|
-0.131000
|
2.86e-01
|
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK
|
14
|
3.96e-01
|
-0.131000
|
5.95e-01
|
GABA RECEPTOR ACTIVATION
|
37
|
1.71e-01
|
-0.130000
|
3.52e-01
|
PEPTIDE HORMONE METABOLISM
|
34
|
1.94e-01
|
-0.129000
|
3.80e-01
|
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX
|
30
|
2.23e-01
|
0.129000
|
4.15e-01
|
VLDLR INTERNALISATION AND DEGRADATION
|
15
|
3.88e-01
|
-0.129000
|
5.89e-01
|
SIGNALING BY GPCR
|
323
|
7.64e-05
|
-0.128000
|
1.01e-03
|
SIGNALING BY INSULIN RECEPTOR
|
56
|
9.71e-02
|
-0.128000
|
2.40e-01
|
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
|
12
|
4.43e-01
|
-0.128000
|
6.47e-01
|
SIGNALLING TO ERKS
|
25
|
2.69e-01
|
-0.128000
|
4.66e-01
|
DEVELOPMENTAL BIOLOGY
|
316
|
9.87e-05
|
-0.128000
|
1.17e-03
|
MACROAUTOPHAGY
|
119
|
1.63e-02
|
-0.128000
|
6.54e-02
|
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL
|
12
|
4.44e-01
|
0.128000
|
6.47e-01
|
HDMS DEMETHYLATE HISTONES
|
21
|
3.14e-01
|
0.127000
|
5.12e-01
|
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1
|
22
|
3.05e-01
|
0.126000
|
5.06e-01
|
RAB REGULATION OF TRAFFICKING
|
109
|
2.32e-02
|
-0.126000
|
8.38e-02
|
ENDOGENOUS STEROLS
|
17
|
3.69e-01
|
-0.126000
|
5.73e-01
|
DNA DOUBLE STRAND BREAK RESPONSE
|
41
|
1.64e-01
|
0.126000
|
3.42e-01
|
G ALPHA Q SIGNALLING EVENTS
|
116
|
1.94e-02
|
-0.126000
|
7.50e-02
|
METABOLISM OF AMINO ACIDS AND DERIVATIVES
|
187
|
3.19e-03
|
-0.125000
|
1.92e-02
|
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
|
30
|
2.36e-01
|
-0.125000
|
4.28e-01
|
RHO GTPASE CYCLE
|
390
|
2.46e-05
|
-0.125000
|
4.35e-04
|
MITOTIC TELOPHASE CYTOKINESIS
|
13
|
4.36e-01
|
0.125000
|
6.41e-01
|
METABOLISM OF VITAMINS AND COFACTORS
|
157
|
7.13e-03
|
-0.125000
|
3.55e-02
|
PROCESSING AND ACTIVATION OF SUMO
|
10
|
4.98e-01
|
-0.124000
|
6.87e-01
|
EPH EPHRIN MEDIATED REPULSION OF CELLS
|
28
|
2.59e-01
|
0.123000
|
4.56e-01
|
PI METABOLISM
|
72
|
7.12e-02
|
-0.123000
|
1.92e-01
|
SIGNALLING TO RAS
|
12
|
4.61e-01
|
-0.123000
|
6.60e-01
|
JOSEPHIN DOMAIN DUBS
|
10
|
5.01e-01
|
0.123000
|
6.90e-01
|
CLASS B 2 SECRETIN FAMILY RECEPTORS
|
28
|
2.61e-01
|
-0.123000
|
4.58e-01
|
HEME DEGRADATION
|
10
|
5.03e-01
|
-0.122000
|
6.91e-01
|
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
|
39
|
1.87e-01
|
-0.122000
|
3.72e-01
|
RAC3 GTPASE CYCLE
|
82
|
5.65e-02
|
-0.122000
|
1.64e-01
|
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE
|
28
|
2.66e-01
|
-0.122000
|
4.62e-01
|
MITOTIC PROPHASE
|
67
|
8.58e-02
|
-0.121000
|
2.20e-01
|
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION
|
89
|
4.85e-02
|
-0.121000
|
1.48e-01
|
CDC42 GTPASE CYCLE
|
90
|
4.84e-02
|
-0.121000
|
1.48e-01
|
AURKA ACTIVATION BY TPX2
|
68
|
8.93e-02
|
-0.119000
|
2.25e-01
|
SYNTHESIS OF PA
|
25
|
3.03e-01
|
-0.119000
|
5.03e-01
|
GAP JUNCTION DEGRADATION
|
11
|
4.94e-01
|
-0.119000
|
6.87e-01
|
SHC MEDIATED CASCADE FGFR4
|
11
|
4.96e-01
|
-0.119000
|
6.87e-01
|
FCERI MEDIATED MAPK ACTIVATION
|
26
|
2.97e-01
|
-0.118000
|
4.98e-01
|
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
|
11
|
4.98e-01
|
-0.118000
|
6.87e-01
|
NONSENSE MEDIATED DECAY NMD INDEPENDENT OF THE EXON JUNCTION COMPLEX EJC
|
88
|
5.60e-02
|
-0.118000
|
1.63e-01
|
RNA POLYMERASE II TRANSCRIBES SNRNA GENES
|
68
|
9.29e-02
|
0.118000
|
2.31e-01
|
LYSINE CATABOLISM
|
10
|
5.19e-01
|
-0.118000
|
7.00e-01
|
RESOLUTION OF SISTER CHROMATID COHESION
|
102
|
4.03e-02
|
-0.118000
|
1.30e-01
|
CELL CYCLE CHECKPOINTS
|
226
|
2.38e-03
|
-0.118000
|
1.53e-02
|
INTERFERON SIGNALING
|
115
|
2.96e-02
|
-0.118000
|
1.02e-01
|
PI 3K CASCADE FGFR4
|
12
|
4.83e-01
|
-0.117000
|
6.80e-01
|
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION
|
273
|
9.44e-04
|
-0.117000
|
7.08e-03
|
PHOSPHOLIPID METABOLISM
|
157
|
1.19e-02
|
-0.116000
|
5.31e-02
|
CELL JUNCTION ORGANIZATION
|
59
|
1.23e-01
|
-0.116000
|
2.86e-01
|
FGFR2 ALTERNATIVE SPLICING
|
17
|
4.07e-01
|
-0.116000
|
6.06e-01
|
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
|
13
|
4.69e-01
|
-0.116000
|
6.65e-01
|
P75NTR RECRUITS SIGNALLING COMPLEXES
|
13
|
4.69e-01
|
0.116000
|
6.65e-01
|
SUMOYLATION OF RNA BINDING PROTEINS
|
45
|
1.80e-01
|
0.116000
|
3.63e-01
|
TGFBR3 PTM REGULATION
|
10
|
5.30e-01
|
0.115000
|
7.11e-01
|
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE
|
26
|
3.11e-01
|
0.115000
|
5.11e-01
|
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION
|
14
|
4.58e-01
|
0.115000
|
6.59e-01
|
HDACS DEACETYLATE HISTONES
|
29
|
2.86e-01
|
-0.115000
|
4.84e-01
|
NONHOMOLOGOUS END JOINING NHEJ
|
31
|
2.70e-01
|
0.114000
|
4.67e-01
|
REGULATION OF TP53 DEGRADATION
|
34
|
2.50e-01
|
-0.114000
|
4.45e-01
|
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
|
20
|
3.78e-01
|
-0.114000
|
5.82e-01
|
S PHASE
|
140
|
2.03e-02
|
-0.114000
|
7.71e-02
|
MAJOR PATHWAY OF RRNA PROCESSING IN THE NUCLEOLUS AND CYTOSOL
|
164
|
1.25e-02
|
-0.113000
|
5.46e-02
|
NUCLEOTIDE CATABOLISM
|
28
|
3.00e-01
|
-0.113000
|
5.01e-01
|
ATTENUATION PHASE
|
13
|
4.84e-01
|
0.112000
|
6.80e-01
|
G0 AND EARLY G1
|
16
|
4.40e-01
|
-0.112000
|
6.44e-01
|
MTORC1 MEDIATED SIGNALLING
|
24
|
3.46e-01
|
-0.111000
|
5.50e-01
|
REGULATION OF INSULIN SECRETION
|
49
|
1.81e-01
|
-0.110000
|
3.63e-01
|
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
|
23
|
3.62e-01
|
-0.110000
|
5.68e-01
|
ESR MEDIATED SIGNALING
|
102
|
5.58e-02
|
-0.110000
|
1.63e-01
|
CALCINEURIN ACTIVATES NFAT
|
10
|
5.49e-01
|
0.109000
|
7.27e-01
|
METABOLISM OF COFACTORS
|
23
|
3.64e-01
|
-0.109000
|
5.71e-01
|
REGULATION OF TLR BY ENDOGENOUS LIGAND
|
15
|
4.64e-01
|
-0.109000
|
6.62e-01
|
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
|
11
|
5.31e-01
|
-0.109000
|
7.11e-01
|
CHROMOSOME MAINTENANCE
|
66
|
1.27e-01
|
0.109000
|
2.92e-01
|
RHOG GTPASE CYCLE
|
67
|
1.25e-01
|
-0.109000
|
2.87e-01
|
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF
|
10
|
5.53e-01
|
0.108000
|
7.28e-01
|
RHOA GTPASE CYCLE
|
132
|
3.25e-02
|
-0.108000
|
1.08e-01
|
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R
|
33
|
2.84e-01
|
-0.108000
|
4.81e-01
|
SIGNALING BY WNT
|
201
|
8.62e-03
|
-0.108000
|
4.15e-02
|
TOLL LIKE RECEPTOR 9 TLR9 CASCADE
|
93
|
7.36e-02
|
-0.107000
|
1.96e-01
|
MTOR SIGNALLING
|
41
|
2.36e-01
|
-0.107000
|
4.28e-01
|
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR
|
21
|
3.97e-01
|
0.107000
|
5.96e-01
|
PYRUVATE METABOLISM
|
42
|
2.33e-01
|
0.106000
|
4.28e-01
|
G ALPHA 12 13 SIGNALLING EVENTS
|
69
|
1.27e-01
|
-0.106000
|
2.92e-01
|
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
|
14
|
4.96e-01
|
-0.105000
|
6.87e-01
|
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
|
12
|
5.29e-01
|
-0.105000
|
7.11e-01
|
SURFACTANT METABOLISM
|
14
|
4.99e-01
|
-0.104000
|
6.87e-01
|
TRANSCRIPTIONAL REGULATION BY RUNX1
|
120
|
4.89e-02
|
-0.104000
|
1.48e-01
|
OXIDATIVE STRESS INDUCED SENESCENCE
|
37
|
2.73e-01
|
0.104000
|
4.68e-01
|
MITOTIC SPINDLE CHECKPOINT
|
96
|
7.95e-02
|
-0.104000
|
2.07e-01
|
G ALPHA S SIGNALLING EVENTS
|
62
|
1.59e-01
|
-0.103000
|
3.36e-01
|
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1
|
10
|
5.73e-01
|
0.103000
|
7.41e-01
|
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
|
34
|
3.00e-01
|
-0.103000
|
5.01e-01
|
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
|
18
|
4.52e-01
|
0.102000
|
6.54e-01
|
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION
|
12
|
5.40e-01
|
0.102000
|
7.16e-01
|
DUAL INCISION IN TC NER
|
61
|
1.68e-01
|
0.102000
|
3.49e-01
|
GLYCOSPHINGOLIPID METABOLISM
|
42
|
2.53e-01
|
-0.102000
|
4.49e-01
|
APOPTOTIC EXECUTION PHASE
|
42
|
2.55e-01
|
-0.102000
|
4.50e-01
|
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX
|
15
|
4.96e-01
|
0.102000
|
6.87e-01
|
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
|
23
|
4.00e-01
|
-0.101000
|
5.97e-01
|
BLOOD GROUP SYSTEMS BIOSYNTHESIS
|
12
|
5.44e-01
|
-0.101000
|
7.22e-01
|
MITF M REGULATED MELANOCYTE DEVELOPMENT
|
29
|
3.49e-01
|
-0.101000
|
5.53e-01
|
SIGNALING BY NOTCH1
|
18
|
4.61e-01
|
0.100000
|
6.60e-01
|
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
|
10
|
5.84e-01
|
-0.100000
|
7.43e-01
|
GLYCEROPHOSPHOLIPID BIOSYNTHESIS
|
86
|
1.11e-01
|
-0.099500
|
2.66e-01
|
PLASMA LIPOPROTEIN REMODELING
|
19
|
4.53e-01
|
-0.099500
|
6.54e-01
|
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES
|
83
|
1.20e-01
|
-0.098800
|
2.83e-01
|
PI 3K CASCADE FGFR3
|
12
|
5.55e-01
|
-0.098400
|
7.28e-01
|
SHC MEDIATED CASCADE FGFR3
|
11
|
5.72e-01
|
-0.098300
|
7.41e-01
|
INTEGRATION OF ENERGY METABOLISM
|
59
|
1.92e-01
|
-0.098300
|
3.78e-01
|
ASPIRIN ADME
|
17
|
4.84e-01
|
-0.098000
|
6.80e-01
|
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER
|
73
|
1.48e-01
|
0.098000
|
3.25e-01
|
RAB GERANYLGERANYLATION
|
52
|
2.23e-01
|
-0.097800
|
4.15e-01
|
MATURATION OF TCA ENZYMES AND REGULATION OF TCA CYCLE
|
18
|
4.78e-01
|
0.096500
|
6.77e-01
|
SPHINGOLIPID METABOLISM
|
72
|
1.57e-01
|
-0.096500
|
3.36e-01
|
VXPX CARGO TARGETING TO CILIUM
|
17
|
4.91e-01
|
-0.096500
|
6.87e-01
|
AFLATOXIN ACTIVATION AND DETOXIFICATION
|
10
|
5.98e-01
|
-0.096400
|
7.52e-01
|
SIGNALING BY PTK6
|
44
|
2.71e-01
|
-0.096000
|
4.67e-01
|
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA
|
31
|
3.55e-01
|
-0.096000
|
5.60e-01
|
HEME SIGNALING
|
12
|
5.65e-01
|
0.095900
|
7.36e-01
|
SIGNALING BY TGFB FAMILY MEMBERS
|
105
|
8.99e-02
|
-0.095900
|
2.25e-01
|
CELL CYCLE
|
508
|
2.76e-04
|
-0.094800
|
2.67e-03
|
TRANSCRIPTIONAL AND POST TRANSLATIONAL REGULATION OF MITF M EXPRESSION AND ACTIVITY
|
16
|
5.12e-01
|
-0.094700
|
6.95e-01
|
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS
|
72
|
1.65e-01
|
0.094700
|
3.44e-01
|
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
|
11
|
5.88e-01
|
0.094300
|
7.44e-01
|
GLUTAMATE AND GLUTAMINE METABOLISM
|
10
|
6.07e-01
|
-0.094100
|
7.59e-01
|
SIGNALING BY ROBO RECEPTORS
|
20
|
4.67e-01
|
-0.094000
|
6.64e-01
|
FORMATION OF INCISION COMPLEX IN GG NER
|
43
|
2.91e-01
|
0.093000
|
4.90e-01
|
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
|
11
|
5.96e-01
|
0.092400
|
7.51e-01
|
INOSITOL PHOSPHATE METABOLISM
|
42
|
3.01e-01
|
-0.092200
|
5.01e-01
|
AMPLIFICATION OF SIGNAL FROM THE KINETOCHORES
|
79
|
1.58e-01
|
-0.092000
|
3.36e-01
|
DUAL INCISION IN GG NER
|
41
|
3.09e-01
|
0.091800
|
5.09e-01
|
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT
|
135
|
6.72e-02
|
-0.091400
|
1.86e-01
|
STRIATED MUSCLE CONTRACTION
|
29
|
3.95e-01
|
-0.091200
|
5.95e-01
|
NONSENSE MEDIATED DECAY NMD
|
107
|
1.04e-01
|
-0.091100
|
2.54e-01
|
CARNITINE METABOLISM
|
14
|
5.55e-01
|
-0.091100
|
7.28e-01
|
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS
|
12
|
5.86e-01
|
-0.090900
|
7.44e-01
|
RHOQ GTPASE CYCLE
|
56
|
2.41e-01
|
-0.090600
|
4.33e-01
|
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK
|
29
|
4.00e-01
|
-0.090300
|
5.97e-01
|
INSULIN RECEPTOR SIGNALLING CASCADE
|
33
|
3.71e-01
|
-0.090100
|
5.74e-01
|
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
|
13
|
5.75e-01
|
-0.089900
|
7.41e-01
|
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS
|
34
|
3.67e-01
|
0.089500
|
5.71e-01
|
RHOC GTPASE CYCLE
|
65
|
2.13e-01
|
-0.089400
|
4.04e-01
|
METABOLISM OF PORPHYRINS
|
21
|
4.79e-01
|
-0.089200
|
6.77e-01
|
SIGNALING BY NUCLEAR RECEPTORS
|
144
|
6.92e-02
|
-0.087900
|
1.88e-01
|
INTRAFLAGELLAR TRANSPORT
|
40
|
3.37e-01
|
-0.087700
|
5.42e-01
|
MYD88 MAL TIRAP CASCADE INITIATED ON PLASMA MEMBRANE
|
81
|
1.73e-01
|
-0.087700
|
3.52e-01
|
POST TRANSLATIONAL PROTEIN MODIFICATION
|
1089
|
1.78e-06
|
-0.086700
|
6.41e-05
|
CELLULAR RESPONSES TO STIMULI
|
420
|
2.42e-03
|
-0.086600
|
1.55e-02
|
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS
|
11
|
6.21e-01
|
-0.086200
|
7.68e-01
|
SIGNALING BY ERYTHROPOIETIN
|
16
|
5.51e-01
|
-0.086200
|
7.28e-01
|
NEDDYLATION
|
207
|
3.44e-02
|
-0.085500
|
1.12e-01
|
NOD1 2 SIGNALING PATHWAY
|
30
|
4.19e-01
|
-0.085200
|
6.21e-01
|
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING
|
12
|
6.16e-01
|
0.083700
|
7.65e-01
|
SIGNALING BY EGFR
|
43
|
3.49e-01
|
-0.082600
|
5.53e-01
|
TRANSMISSION ACROSS CHEMICAL SYNAPSES
|
130
|
1.06e-01
|
-0.082200
|
2.57e-01
|
METABOLISM OF PROTEINS
|
1445
|
3.21e-07
|
-0.081600
|
1.60e-05
|
SIGNALING BY TGF BETA RECEPTOR COMPLEX
|
73
|
2.34e-01
|
-0.080600
|
4.28e-01
|
MITOTIC PROMETAPHASE
|
171
|
7.33e-02
|
-0.079500
|
1.96e-01
|
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN
|
16
|
5.83e-01
|
-0.079400
|
7.43e-01
|
REGULATION OF TNFR1 SIGNALING
|
46
|
3.54e-01
|
-0.079100
|
5.58e-01
|
PROTEIN UBIQUITINATION
|
56
|
3.08e-01
|
-0.078700
|
5.08e-01
|
TRANSLATION
|
218
|
4.57e-02
|
-0.078700
|
1.43e-01
|
SPRY REGULATION OF FGF SIGNALING
|
16
|
5.87e-01
|
0.078400
|
7.44e-01
|
PINK1 PRKN MEDIATED MITOPHAGY
|
30
|
4.61e-01
|
-0.077700
|
6.60e-01
|
VOLTAGE GATED POTASSIUM CHANNELS
|
21
|
5.38e-01
|
0.077700
|
7.16e-01
|
SPHINGOLIPID DE NOVO BIOSYNTHESIS
|
21
|
5.38e-01
|
-0.077600
|
7.16e-01
|
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS
|
10
|
6.71e-01
|
0.077500
|
8.11e-01
|
POTASSIUM CHANNELS
|
56
|
3.19e-01
|
-0.077100
|
5.17e-01
|
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION
|
12
|
6.45e-01
|
-0.076900
|
7.89e-01
|
WNT LIGAND BIOGENESIS AND TRAFFICKING
|
13
|
6.31e-01
|
0.076900
|
7.77e-01
|
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
|
25
|
5.07e-01
|
-0.076700
|
6.95e-01
|
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE
|
66
|
2.83e-01
|
0.076500
|
4.80e-01
|
ESTROGEN DEPENDENT GENE EXPRESSION
|
43
|
3.88e-01
|
0.076100
|
5.89e-01
|
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE
|
19
|
5.67e-01
|
-0.075800
|
7.38e-01
|
PLATELET CALCIUM HOMEOSTASIS
|
22
|
5.39e-01
|
-0.075600
|
7.16e-01
|
BASIGIN INTERACTIONS
|
18
|
5.79e-01
|
-0.075500
|
7.41e-01
|
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER
|
81
|
2.42e-01
|
0.075200
|
4.34e-01
|
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
|
34
|
4.51e-01
|
0.074800
|
6.54e-01
|
FORMATION OF FIBRIN CLOT CLOTTING CASCADE
|
19
|
5.74e-01
|
-0.074500
|
7.41e-01
|
RNA POLYMERASE I TRANSCRIPTION TERMINATION
|
26
|
5.11e-01
|
0.074500
|
6.95e-01
|
TNFR1 INDUCED NF KAPPA B SIGNALING PATHWAY
|
32
|
4.67e-01
|
-0.074300
|
6.64e-01
|
BIOLOGICAL OXIDATIONS
|
130
|
1.46e-01
|
-0.073900
|
3.23e-01
|
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE
|
10
|
6.86e-01
|
0.073800
|
8.26e-01
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2
|
19
|
5.78e-01
|
-0.073700
|
7.41e-01
|
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS
|
104
|
1.95e-01
|
-0.073600
|
3.80e-01
|
TELOMERE EXTENSION BY TELOMERASE
|
17
|
6.00e-01
|
0.073400
|
7.52e-01
|
NUCLEOTIDE EXCISION REPAIR
|
105
|
1.95e-01
|
0.073300
|
3.80e-01
|
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE
|
26
|
5.21e-01
|
-0.072800
|
7.01e-01
|
NEGATIVE REGULATION OF MET ACTIVITY
|
20
|
5.76e-01
|
0.072300
|
7.41e-01
|
PARACETAMOL ADME
|
20
|
5.76e-01
|
-0.072200
|
7.41e-01
|
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION
|
28
|
5.11e-01
|
-0.071700
|
6.95e-01
|
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION
|
80
|
2.70e-01
|
-0.071400
|
4.67e-01
|
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION
|
22
|
5.63e-01
|
-0.071300
|
7.35e-01
|
NOTCH HLH TRANSCRIPTION PATHWAY
|
22
|
5.63e-01
|
-0.071300
|
7.35e-01
|
FORMATION OF RNA POL II ELONGATION COMPLEX
|
51
|
3.80e-01
|
-0.071100
|
5.84e-01
|
METABOLISM OF RNA
|
559
|
4.39e-03
|
-0.070900
|
2.52e-02
|
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING
|
13
|
6.59e-01
|
0.070800
|
8.02e-01
|
STIMULI SENSING CHANNELS
|
62
|
3.39e-01
|
-0.070300
|
5.42e-01
|
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS
|
37
|
4.64e-01
|
-0.069600
|
6.62e-01
|
SIGNALING BY ERBB2
|
40
|
4.48e-01
|
-0.069400
|
6.51e-01
|
TERMINATION OF TRANSLESION DNA SYNTHESIS
|
31
|
5.04e-01
|
0.069300
|
6.92e-01
|
RNA POLYMERASE I TRANSCRIPTION
|
41
|
4.51e-01
|
-0.068000
|
6.54e-01
|
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX
|
24
|
5.65e-01
|
0.067900
|
7.36e-01
|
THE PHOTOTRANSDUCTION CASCADE
|
17
|
6.28e-01
|
-0.067800
|
7.75e-01
|
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN
|
65
|
3.45e-01
|
-0.067700
|
5.50e-01
|
ESTABLISHMENT OF SISTER CHROMATID COHESION
|
10
|
7.11e-01
|
0.067700
|
8.39e-01
|
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
|
16
|
6.41e-01
|
-0.067400
|
7.87e-01
|
TRAFFICKING OF AMPA RECEPTORS
|
22
|
5.86e-01
|
-0.067100
|
7.44e-01
|
MITOCHONDRIAL PROTEIN DEGRADATION
|
70
|
3.39e-01
|
0.066100
|
5.42e-01
|
ABC TRANSPORTERS IN LIPID HOMEOSTASIS
|
14
|
6.70e-01
|
0.065800
|
8.11e-01
|
RHOBTB GTPASE CYCLE
|
34
|
5.11e-01
|
0.065200
|
6.95e-01
|
BASE EXCISION REPAIR AP SITE FORMATION
|
15
|
6.63e-01
|
-0.065000
|
8.05e-01
|
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
|
17
|
6.43e-01
|
0.065000
|
7.88e-01
|
METABOLISM OF LIPIDS
|
463
|
1.83e-02
|
-0.064300
|
7.14e-02
|
RAF ACTIVATION
|
34
|
5.17e-01
|
-0.064300
|
6.98e-01
|
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE
|
92
|
2.88e-01
|
-0.064200
|
4.86e-01
|
LGI ADAM INTERACTIONS
|
10
|
7.27e-01
|
-0.063700
|
8.43e-01
|
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
|
42
|
4.85e-01
|
-0.062300
|
6.80e-01
|
MET RECEPTOR RECYCLING
|
10
|
7.33e-01
|
-0.062200
|
8.46e-01
|
HYALURONAN METABOLISM
|
14
|
6.87e-01
|
-0.062200
|
8.26e-01
|
UNFOLDED PROTEIN RESPONSE UPR
|
10
|
7.36e-01
|
-0.061600
|
8.47e-01
|
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
|
21
|
6.27e-01
|
-0.061300
|
7.74e-01
|
AMINE LIGAND BINDING RECEPTORS
|
14
|
6.93e-01
|
-0.061000
|
8.29e-01
|
MUSCLE CONTRACTION
|
126
|
2.39e-01
|
-0.060800
|
4.32e-01
|
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE
|
23
|
6.21e-01
|
0.059500
|
7.68e-01
|
HEME BIOSYNTHESIS
|
12
|
7.23e-01
|
-0.059100
|
8.39e-01
|
GLYCOSPHINGOLIPID CATABOLISM
|
28
|
5.89e-01
|
-0.059000
|
7.45e-01
|
REGULATION OF TP53 ACTIVITY
|
145
|
2.23e-01
|
-0.058700
|
4.15e-01
|
FRS MEDIATED FGFR1 SIGNALING
|
13
|
7.16e-01
|
-0.058300
|
8.39e-01
|
RNA POLYMERASE II PROMOTER ESCAPE
|
44
|
5.13e-01
|
0.057000
|
6.95e-01
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4
|
18
|
6.78e-01
|
-0.056500
|
8.18e-01
|
METABOLISM
|
1435
|
4.44e-04
|
-0.056200
|
3.96e-03
|
NEURONAL SYSTEM
|
202
|
1.69e-01
|
-0.056200
|
3.50e-01
|
KSRP KHSRP BINDS AND DESTABILIZES MRNA
|
14
|
7.16e-01
|
0.056100
|
8.39e-01
|
NUCLEOTIDE BIOSYNTHESIS
|
12
|
7.37e-01
|
0.056100
|
8.47e-01
|
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS
|
49
|
4.98e-01
|
-0.056000
|
6.87e-01
|
AMINO ACIDS REGULATE MTORC1
|
46
|
5.11e-01
|
0.056000
|
6.95e-01
|
MITOCHONDRIAL FATTY ACID BETA OXIDATION
|
33
|
5.79e-01
|
0.055800
|
7.41e-01
|
FRS MEDIATED FGFR2 SIGNALING
|
14
|
7.18e-01
|
-0.055700
|
8.39e-01
|
GENE EXPRESSION TRANSCRIPTION
|
921
|
4.60e-03
|
0.055600
|
2.57e-02
|
COMMON PATHWAY OF FIBRIN CLOT FORMATION
|
12
|
7.40e-01
|
-0.055400
|
8.48e-01
|
RIPK1 MEDIATED REGULATED NECROSIS
|
29
|
6.08e-01
|
-0.055100
|
7.59e-01
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1
|
21
|
6.62e-01
|
-0.055100
|
8.05e-01
|
DEADENYLATION DEPENDENT MRNA DECAY
|
48
|
5.13e-01
|
-0.054600
|
6.95e-01
|
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR
|
53
|
4.92e-01
|
0.054600
|
6.87e-01
|
FCERI MEDIATED CA 2 MOBILIZATION
|
23
|
6.52e-01
|
-0.054400
|
7.97e-01
|
MET ACTIVATES RAP1 AND RAC1
|
11
|
7.56e-01
|
-0.054000
|
8.61e-01
|
PROTEIN HYDROXYLATION
|
16
|
7.10e-01
|
0.053700
|
8.39e-01
|
VITAMIN B5 PANTOTHENATE METABOLISM
|
14
|
7.29e-01
|
-0.053400
|
8.44e-01
|
FORMATION OF TC NER PRE INCISION COMPLEX
|
49
|
5.19e-01
|
0.053200
|
7.00e-01
|
SIGNALING BY NOTCH3
|
19
|
6.92e-01
|
-0.052600
|
8.29e-01
|
RND2 GTPASE CYCLE
|
37
|
5.82e-01
|
0.052300
|
7.43e-01
|
O LINKED GLYCOSYLATION
|
72
|
4.43e-01
|
-0.052300
|
6.47e-01
|
ION CHANNEL TRANSPORT
|
118
|
3.31e-01
|
-0.051900
|
5.33e-01
|
GENERIC TRANSCRIPTION PATHWAY
|
690
|
2.19e-02
|
0.051500
|
8.13e-02
|
SULFUR AMINO ACID METABOLISM
|
19
|
6.99e-01
|
-0.051300
|
8.33e-01
|
FATTY ACID METABOLISM
|
133
|
3.08e-01
|
-0.051300
|
5.08e-01
|
RND3 GTPASE CYCLE
|
36
|
5.99e-01
|
-0.050700
|
7.52e-01
|
SUMOYLATION OF SUMOYLATION PROTEINS
|
33
|
6.15e-01
|
0.050700
|
7.65e-01
|
PROTEIN METHYLATION
|
17
|
7.19e-01
|
-0.050400
|
8.39e-01
|
TRANSLESION SYNTHESIS BY POLH
|
18
|
7.14e-01
|
-0.050000
|
8.39e-01
|
HDR THROUGH SINGLE STRAND ANNEALING SSA
|
34
|
6.15e-01
|
0.049900
|
7.65e-01
|
SNRNP ASSEMBLY
|
47
|
5.58e-01
|
0.049500
|
7.31e-01
|
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES
|
40
|
5.91e-01
|
0.049100
|
7.46e-01
|
SIGNAL TRANSDUCTION BY L1
|
19
|
7.13e-01
|
-0.048800
|
8.39e-01
|
PKR MEDIATED SIGNALING
|
60
|
5.14e-01
|
-0.048700
|
6.96e-01
|
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
|
11
|
7.85e-01
|
-0.047500
|
8.80e-01
|
RHOD GTPASE CYCLE
|
49
|
5.68e-01
|
-0.047100
|
7.38e-01
|
HOMOLOGY DIRECTED REPAIR
|
93
|
4.33e-01
|
0.047100
|
6.38e-01
|
KERATAN SULFATE KERATIN METABOLISM
|
28
|
6.67e-01
|
-0.047000
|
8.08e-01
|
RND1 GTPASE CYCLE
|
38
|
6.16e-01
|
0.047000
|
7.65e-01
|
CYCLIN D ASSOCIATED EVENTS IN G1
|
41
|
6.07e-01
|
-0.046400
|
7.59e-01
|
AZATHIOPRINE ADME
|
20
|
7.22e-01
|
0.046000
|
8.39e-01
|
TNF SIGNALING
|
55
|
5.55e-01
|
-0.046000
|
7.28e-01
|
TRANSCRIPTIONAL REGULATION BY SMALL RNAS
|
32
|
6.58e-01
|
0.045200
|
8.02e-01
|
SLC MEDIATED TRANSMEMBRANE TRANSPORT
|
168
|
3.14e-01
|
-0.045100
|
5.12e-01
|
FORMATION OF THE EARLY ELONGATION COMPLEX
|
32
|
6.59e-01
|
-0.045100
|
8.02e-01
|
CELLULAR RESPONSE TO HEAT STRESS
|
81
|
4.84e-01
|
-0.045000
|
6.80e-01
|
FLT3 SIGNALING
|
26
|
6.92e-01
|
0.045000
|
8.29e-01
|
DNA DOUBLE STRAND BREAK REPAIR
|
123
|
3.90e-01
|
0.044900
|
5.90e-01
|
NETRIN 1 SIGNALING
|
12
|
7.88e-01
|
-0.044900
|
8.81e-01
|
ACTIVATION OF THE PRE REPLICATIVE COMPLEX
|
31
|
6.67e-01
|
0.044600
|
8.08e-01
|
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
|
79
|
4.94e-01
|
-0.044500
|
6.87e-01
|
RHOB GTPASE CYCLE
|
65
|
5.36e-01
|
-0.044400
|
7.16e-01
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3
|
18
|
7.46e-01
|
-0.044100
|
8.51e-01
|
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
|
12
|
7.92e-01
|
-0.043900
|
8.84e-01
|
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA
|
16
|
7.61e-01
|
0.043800
|
8.65e-01
|
SIGNALING BY FGFR
|
62
|
5.53e-01
|
-0.043600
|
7.28e-01
|
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
|
11
|
8.04e-01
|
-0.043200
|
8.94e-01
|
ORGANELLE BIOGENESIS AND MAINTENANCE
|
171
|
3.38e-01
|
-0.042600
|
5.42e-01
|
BASE EXCISION REPAIR
|
42
|
6.36e-01
|
0.042200
|
7.82e-01
|
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
|
10
|
8.24e-01
|
0.040700
|
9.10e-01
|
TIE2 SIGNALING
|
16
|
7.85e-01
|
-0.039500
|
8.80e-01
|
TBC RABGAPS
|
33
|
6.95e-01
|
-0.039500
|
8.31e-01
|
MITOCHONDRIAL TRANSLATION
|
87
|
5.37e-01
|
0.038300
|
7.16e-01
|
SIGNALING BY RETINOIC ACID
|
34
|
7.00e-01
|
-0.038200
|
8.34e-01
|
INTERLEUKIN 17 SIGNALING
|
57
|
6.19e-01
|
-0.038100
|
7.67e-01
|
PURINE CATABOLISM
|
16
|
7.94e-01
|
0.037800
|
8.84e-01
|
NEUROTRANSMITTER RELEASE CYCLE
|
30
|
7.22e-01
|
-0.037600
|
8.39e-01
|
TP53 REGULATES METABOLIC GENES
|
66
|
5.99e-01
|
0.037500
|
7.52e-01
|
PEROXISOMAL LIPID METABOLISM
|
27
|
7.38e-01
|
-0.037200
|
8.47e-01
|
PROCESSING OF CAPPED INTRONLESS PRE MRNA
|
28
|
7.36e-01
|
-0.036900
|
8.47e-01
|
SIGNALING BY TGFBR3
|
21
|
7.71e-01
|
-0.036700
|
8.74e-01
|
DARPP 32 EVENTS
|
15
|
8.08e-01
|
-0.036300
|
8.96e-01
|
GENE SILENCING BY RNA
|
40
|
6.98e-01
|
0.035500
|
8.33e-01
|
SUMOYLATION OF UBIQUITINYLATION PROTEINS
|
37
|
7.10e-01
|
0.035300
|
8.39e-01
|
KERATAN SULFATE BIOSYNTHESIS
|
21
|
7.81e-01
|
-0.035100
|
8.80e-01
|
ADHERENS JUNCTIONS INTERACTIONS
|
29
|
7.45e-01
|
-0.034900
|
8.51e-01
|
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS
|
41
|
7.11e-01
|
-0.033500
|
8.39e-01
|
PROTEIN LOCALIZATION
|
95
|
5.81e-01
|
-0.032800
|
7.43e-01
|
ELEVATION OF CYTOSOLIC CA2 LEVELS
|
10
|
8.58e-01
|
0.032700
|
9.29e-01
|
RESOLUTION OF ABASIC SITES AP SITES
|
37
|
7.33e-01
|
0.032400
|
8.46e-01
|
NUCLEAR ENVELOPE BREAKDOWN
|
45
|
7.08e-01
|
-0.032300
|
8.39e-01
|
SUMOYLATION OF DNA REPLICATION PROTEINS
|
41
|
7.21e-01
|
0.032200
|
8.39e-01
|
RHOBTB2 GTPASE CYCLE
|
22
|
7.96e-01
|
0.031900
|
8.85e-01
|
PROTEIN LIPOYLATION
|
10
|
8.62e-01
|
0.031900
|
9.30e-01
|
NEGATIVE REGULATION OF FGFR3 SIGNALING
|
23
|
7.93e-01
|
0.031600
|
8.84e-01
|
MRNA CAPPING
|
28
|
7.73e-01
|
-0.031500
|
8.75e-01
|
DNA REPAIR
|
257
|
3.87e-01
|
0.031400
|
5.89e-01
|
FOXO MEDIATED TRANSCRIPTION
|
20
|
8.11e-01
|
0.030900
|
8.99e-01
|
SIGNALING BY ERBB4
|
32
|
7.63e-01
|
0.030800
|
8.66e-01
|
INTERLEUKIN 15 SIGNALING
|
10
|
8.67e-01
|
0.030600
|
9.30e-01
|
EGFR DOWNREGULATION
|
28
|
7.79e-01
|
-0.030600
|
8.80e-01
|
FRS MEDIATED FGFR4 SIGNALING
|
13
|
8.49e-01
|
-0.030600
|
9.27e-01
|
PEXOPHAGY
|
10
|
8.69e-01
|
-0.030100
|
9.31e-01
|
NEGATIVE REGULATION OF FLT3
|
13
|
8.57e-01
|
-0.028900
|
9.29e-01
|
SIGNALING BY FGFR3
|
32
|
7.78e-01
|
0.028800
|
8.80e-01
|
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS
|
54
|
7.17e-01
|
0.028600
|
8.39e-01
|
SYNTHESIS OF PC
|
21
|
8.23e-01
|
-0.028200
|
9.10e-01
|
GAMMA CARBOXYLATION HYPUSINYLATION HYDROXYLATION AND ARYLSULFATASE ACTIVATION
|
45
|
7.44e-01
|
0.028200
|
8.51e-01
|
DNA DAMAGE BYPASS
|
46
|
7.43e-01
|
0.028000
|
8.51e-01
|
MITF M DEPENDENT GENE EXPRESSION
|
15
|
8.54e-01
|
-0.027400
|
9.29e-01
|
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA
|
34
|
7.83e-01
|
-0.027300
|
8.80e-01
|
SUMOYLATION
|
144
|
5.78e-01
|
0.026900
|
7.41e-01
|
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS
|
56
|
7.29e-01
|
0.026800
|
8.44e-01
|
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
|
10
|
8.84e-01
|
0.026600
|
9.42e-01
|
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES
|
14
|
8.63e-01
|
-0.026600
|
9.30e-01
|
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS
|
10
|
8.87e-01
|
0.026000
|
9.42e-01
|
RNA POLYMERASE II PRE TRANSCRIPTION EVENTS
|
72
|
7.05e-01
|
-0.025900
|
8.38e-01
|
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP
|
38
|
7.86e-01
|
-0.025500
|
8.80e-01
|
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE
|
16
|
8.61e-01
|
-0.025200
|
9.30e-01
|
CELLULAR SENESCENCE
|
91
|
6.84e-01
|
-0.024700
|
8.24e-01
|
PROCESSING OF INTRONLESS PRE MRNAS
|
20
|
8.50e-01
|
-0.024400
|
9.27e-01
|
KERATAN SULFATE DEGRADATION
|
12
|
8.84e-01
|
0.024300
|
9.42e-01
|
NEUREXINS AND NEUROLIGINS
|
21
|
8.52e-01
|
-0.023500
|
9.29e-01
|
METABOLISM OF STEROIDS
|
80
|
7.19e-01
|
0.023300
|
8.39e-01
|
P75 NTR RECEPTOR MEDIATED SIGNALLING
|
79
|
7.22e-01
|
0.023200
|
8.39e-01
|
INTERFERON GAMMA SIGNALING
|
18
|
8.67e-01
|
-0.022900
|
9.30e-01
|
HATS ACETYLATE HISTONES
|
29
|
8.33e-01
|
0.022600
|
9.17e-01
|
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES
|
30
|
8.32e-01
|
-0.022400
|
9.16e-01
|
NEGATIVE REGULATION OF FGFR4 SIGNALING
|
23
|
8.56e-01
|
0.021900
|
9.29e-01
|
SIGNALING BY FGFR4
|
32
|
8.31e-01
|
0.021800
|
9.16e-01
|
PHASE I FUNCTIONALIZATION OF COMPOUNDS
|
56
|
7.83e-01
|
0.021300
|
8.80e-01
|
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
|
15
|
8.88e-01
|
-0.021100
|
9.42e-01
|
GLUTATHIONE CONJUGATION
|
32
|
8.37e-01
|
-0.021000
|
9.19e-01
|
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
|
29
|
8.57e-01
|
-0.019300
|
9.29e-01
|
CA2 PATHWAY
|
37
|
8.39e-01
|
-0.019300
|
9.20e-01
|
NRAGE SIGNALS DEATH THROUGH JNK
|
49
|
8.17e-01
|
0.019100
|
9.04e-01
|
CELL CELL JUNCTION ORGANIZATION
|
37
|
8.41e-01
|
0.019100
|
9.21e-01
|
MITOPHAGY
|
37
|
8.49e-01
|
0.018000
|
9.27e-01
|
ION HOMEOSTASIS
|
45
|
8.35e-01
|
-0.018000
|
9.17e-01
|
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS
|
11
|
9.22e-01
|
0.016900
|
9.66e-01
|
DNA DAMAGE RECOGNITION IN GG NER
|
38
|
8.66e-01
|
0.015900
|
9.30e-01
|
MYOGENESIS
|
17
|
9.11e-01
|
0.015700
|
9.59e-01
|
ONCOGENE INDUCED SENESCENCE
|
16
|
9.19e-01
|
-0.014800
|
9.64e-01
|
DOWNREGULATION OF ERBB2 SIGNALING
|
24
|
9.04e-01
|
-0.014200
|
9.56e-01
|
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES
|
45
|
8.70e-01
|
-0.014100
|
9.31e-01
|
FRS MEDIATED FGFR3 SIGNALING
|
13
|
9.33e-01
|
-0.013400
|
9.71e-01
|
FATTY ACYL COA BIOSYNTHESIS
|
26
|
9.06e-01
|
0.013300
|
9.57e-01
|
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
|
13
|
9.34e-01
|
0.013300
|
9.71e-01
|
SIGNALING BY FGFR2
|
51
|
8.71e-01
|
-0.013100
|
9.31e-01
|
P75NTR SIGNALS VIA NF KB
|
16
|
9.29e-01
|
0.012900
|
9.70e-01
|
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION
|
10
|
9.44e-01
|
0.012700
|
9.74e-01
|
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE
|
34
|
8.98e-01
|
-0.012700
|
9.51e-01
|
PEROXISOMAL PROTEIN IMPORT
|
61
|
8.65e-01
|
0.012600
|
9.30e-01
|
ION TRANSPORT BY P TYPE ATPASES
|
41
|
8.92e-01
|
0.012200
|
9.46e-01
|
ENOS ACTIVATION
|
12
|
9.42e-01
|
-0.012100
|
9.73e-01
|
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION
|
15
|
9.36e-01
|
-0.011900
|
9.71e-01
|
MRNA SPLICING
|
190
|
7.86e-01
|
0.011400
|
8.80e-01
|
TRANSCRIPTIONAL REGULATION BY TP53
|
274
|
7.56e-01
|
-0.010900
|
8.61e-01
|
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION
|
19
|
9.35e-01
|
-0.010800
|
9.71e-01
|
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE
|
37
|
9.10e-01
|
0.010800
|
9.59e-01
|
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION
|
86
|
8.66e-01
|
0.010500
|
9.30e-01
|
RESOLUTION OF D LOOP STRUCTURES
|
29
|
9.23e-01
|
-0.010400
|
9.66e-01
|
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE
|
62
|
8.88e-01
|
-0.010400
|
9.42e-01
|
HSF1 DEPENDENT TRANSACTIVATION
|
23
|
9.34e-01
|
-0.009970
|
9.71e-01
|
REGULATION OF LIPID METABOLISM BY PPARALPHA
|
16
|
9.48e-01
|
-0.009410
|
9.74e-01
|
G2 M DNA DAMAGE CHECKPOINT
|
52
|
9.10e-01
|
-0.009040
|
9.59e-01
|
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION
|
22
|
9.48e-01
|
-0.008030
|
9.74e-01
|
IRON UPTAKE AND TRANSPORT
|
46
|
9.29e-01
|
-0.007560
|
9.70e-01
|
DRUG ADME
|
63
|
9.18e-01
|
-0.007540
|
9.64e-01
|
SIGNALING BY NOTCH
|
38
|
9.37e-01
|
-0.007360
|
9.71e-01
|
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
|
74
|
9.16e-01
|
-0.007120
|
9.63e-01
|
NUCLEAR PORE COMPLEX NPC DISASSEMBLY
|
30
|
9.46e-01
|
-0.007090
|
9.74e-01
|
GROWTH HORMONE RECEPTOR SIGNALING
|
10
|
9.69e-01
|
-0.007080
|
9.88e-01
|
EPHA MEDIATED GROWTH CONE COLLAPSE
|
12
|
9.69e-01
|
0.006430
|
9.88e-01
|
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
|
254
|
8.73e-01
|
0.005840
|
9.32e-01
|
NEGATIVE REGULATION OF FGFR2 SIGNALING
|
24
|
9.66e-01
|
0.005040
|
9.88e-01
|
INFLAMMASOMES
|
12
|
9.77e-01
|
-0.004830
|
9.92e-01
|
CARDIAC CONDUCTION
|
76
|
9.42e-01
|
-0.004820
|
9.73e-01
|
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
|
27
|
9.66e-01
|
-0.004800
|
9.88e-01
|
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION
|
10
|
9.80e-01
|
0.004630
|
9.94e-01
|
SIGNALING BY FGFR1
|
41
|
9.59e-01
|
-0.004620
|
9.84e-01
|
RAS PROCESSING
|
23
|
9.71e-01
|
-0.004390
|
9.88e-01
|
EFFECTS OF PIP2 HYDROLYSIS
|
22
|
9.72e-01
|
0.004320
|
9.88e-01
|
DEATH RECEPTOR SIGNALING
|
131
|
9.33e-01
|
0.004250
|
9.71e-01
|
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
|
40
|
9.68e-01
|
-0.003650
|
9.88e-01
|
CHROMATIN MODIFYING ENZYMES
|
136
|
9.42e-01
|
-0.003600
|
9.73e-01
|
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS
|
36
|
9.71e-01
|
0.003550
|
9.88e-01
|
NR1H2 AND NR1H3 MEDIATED SIGNALING
|
12
|
9.84e-01
|
-0.003350
|
9.94e-01
|
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION
|
14
|
9.84e-01
|
0.003000
|
9.94e-01
|
SIGNALING BY ALK
|
14
|
9.87e-01
|
-0.002520
|
9.94e-01
|
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES
|
30
|
9.83e-01
|
-0.002300
|
9.94e-01
|
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
|
16
|
9.88e-01
|
-0.002120
|
9.94e-01
|
RET SIGNALING
|
34
|
9.83e-01
|
0.002100
|
9.94e-01
|
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
|
11
|
9.93e-01
|
0.001460
|
9.97e-01
|
RNA POLYMERASE II TRANSCRIPTION TERMINATION
|
60
|
9.86e-01
|
0.001270
|
9.94e-01
|
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
|
11
|
9.95e-01
|
-0.001070
|
9.97e-01
|
METABOLISM OF NUCLEOTIDES
|
77
|
9.89e-01
|
-0.000914
|
9.94e-01
|
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
|
23
|
9.95e-01
|
0.000680
|
9.97e-01
|
MRNA SPLICING MINOR PATHWAY
|
47
|
9.95e-01
|
0.000563
|
9.97e-01
|
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
|
23
|
9.97e-01
|
-0.000451
|
9.97e-01
|